Skip to main content
PMC home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1996 Jun;60(2):386–406. doi: 10.1128/mr.60.2.386-406.1996

Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions.

N Chirmule 1, S Pahwa 1
PMCID: PMC239449  PMID: 8801439

Abstract

Infection by human immunodeficiency virus type 1 (HIV-1) leads to progressive destruction of the CD4+ T-cell subset, resulting in immune deficiency and AIDS. The specific binding of the viral external envelope glycoprotein of HIV-1, gp120, to the CD4 molecules initiates viral entry. In the past few years, several studies have indicated that the interaction of HIV-1 envelope glycoprotein with cells and molecules of the immune system leads to pleiotropic biological effects on immune functions, which include effects on differentiation of CD34+ lymphoid progenitor cells and thymocytes, aberrant activation and cytokine secretion patterns of mature T cells, induction of apoptosis, B-cell hyperactivity, inhibition of T-cell dependent B-cell differentiation, modulation of macrophage functions, interactions with components of complement, and effects on neuronal cells. The amino acid sequence homologies of the envelope glycoproteins with several cellular proteins have suggested that molecular mimicry may play a role in the pathogenesis of the disease. This review summarizes work done by several investigators demonstrating the profound biological effects of envelope glycoproteins of HIV-1 on immune system cells. Extensive studies have also been done on interactions of the viral envelope proteins with components of the immune system which may be important for eliciting a "protective immune response." Understanding the influences of HIV-1 envelope glycoproteins on the immune system may provide valuable insights into HIV-1 disease pathogenesis and carries implications for the trials of HIV-1 envelope protein vaccines and immunotherapeutics.

Full Text

The Full Text of this article is available as a PDF (448.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abehsira-Amar O., Gibert M., Joliy M., Thèze J., Jankovic D. L. IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. J Immunol. 1992 Jun 15;148(12):3820–3829. [PubMed] [Google Scholar]
  2. Akolkar P. N., Chirmule N., Gulwani-Akolkar B., Pahwa S., Kalyanaraman V. S., Pergolizzi R., Macphail S., Silver J. V beta-specific activation of T cells by the HIV glycoprotein gp 160. Scand J Immunol. 1995 May;41(5):487–498. doi: 10.1111/j.1365-3083.1995.tb03597.x. [DOI] [PubMed] [Google Scholar]
  3. Akolkar P. N., Gulwani-Akolkar B., Chirmule N., Pahwa S., Kalyanaraman V. S., Pergolizzi R., Macphail S., Silver J. The HIV glycoprotein gp 160 has superantigen-like properties. Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 1):255–265. doi: 10.1006/clin.1995.1124. [DOI] [PubMed] [Google Scholar]
  4. Amadori A., Chieco-Bianchi L. B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today. 1990 Oct;11(10):374–379. doi: 10.1016/0167-5699(90)90144-x. [DOI] [PubMed] [Google Scholar]
  5. Amadori A., De Silvestro G., Zamarchi R., Veronese M. L., Mazza M. R., Schiavo G., Panozzo M., De Rossi A., Ometto L., Mous J. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol. 1992 May 1;148(9):2709–2716. [PubMed] [Google Scholar]
  6. Ameglio F., Capobianchi M. R., Castilletti C., Cordiali Fei P., Fais S., Trento E., Dianzani F. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol. 1994 Mar;95(3):455–458. doi: 10.1111/j.1365-2249.1994.tb07018.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ameisen J. C., Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today. 1991 Apr;12(4):102–105. doi: 10.1016/0167-5699(91)90092-8. [DOI] [PubMed] [Google Scholar]
  8. Amendola A., Lombardi G., Oliverio S., Colizzi V., Piacentini M. HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by 'tissue' transglutaminase expression and prevented by cyclosporin A. FEBS Lett. 1994 Feb 21;339(3):258–264. doi: 10.1016/0014-5793(94)80427-3. [DOI] [PubMed] [Google Scholar]
  9. Ammann A. J., Schiffman G., Abrams D., Volberding P., Ziegler J., Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA. 1984 Mar 16;251(11):1447–1449. [PubMed] [Google Scholar]
  10. Ardman B., Kowalski M., Bristol J., Haseltine W., Sodroski J. Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. J Acquir Immune Defic Syndr. 1990;3(3):206–214. [PubMed] [Google Scholar]
  11. Arthos J., Deen K. C., Chaikin M. A., Fornwald J. A., Sathe G., Sattentau Q. J., Clapham P. R., Weiss R. A., McDougal J. S., Pietropaolo C. Identification of the residues in human CD4 critical for the binding of HIV. Cell. 1989 May 5;57(3):469–481. doi: 10.1016/0092-8674(89)90922-7. [DOI] [PubMed] [Google Scholar]
  12. Atwood W. J., Berger J. R., Kaderman R., Tornatore C. S., Major E. O. Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev. 1993 Oct;6(4):339–366. doi: 10.1128/cmr.6.4.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bagnara G. P., Zauli G., Re M. C., Furlini G., Giovannini M., Ranieri S., Brizzi M. F., La Placa M. Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-gm in HIV-1 seropositive subjects. Int J Cell Cloning. 1991 May;9(3):239–250. doi: 10.1002/stem.5530090308. [DOI] [PubMed] [Google Scholar]
  14. Bahadoran P., Rieux-Laucat F., Le Deist F., Blanche S., Fischer A., de Villartay J. P. Lack of selective V beta deletion in peripheral CD4+ T cells of human immunodeficiency virus-infected infants. Eur J Immunol. 1993 Aug;23(8):2041–2044. doi: 10.1002/eji.1830230850. [DOI] [PubMed] [Google Scholar]
  15. Baldari C. T., Di Somma M. M., Milia E., Bergman M., Telford J. L. Interactions between the tyrosine kinases p56lck, p59fyn and p50csk in CD4 signaling in T cells. Eur J Immunol. 1995 Apr;25(4):919–925. doi: 10.1002/eji.1830250409. [DOI] [PubMed] [Google Scholar]
  16. Baldari C. T., Milia E., Di Somma M. M., Baldoni F., Valitutti S., Telford J. L. Distinct signaling properties identify functionally different CD4 epitopes. Eur J Immunol. 1995 Jul;25(7):1843–1850. doi: 10.1002/eji.1830250708. [DOI] [PubMed] [Google Scholar]
  17. Baldari C. T., Pelicci G., Di Somma M. M., Milia E., Giuli S., Pelicci P. G., Telford J. L. Inhibition of CD4/p56lck signaling by a dominant negative mutant of the Shc adaptor protein. Oncogene. 1995 Mar 16;10(6):1141–1147. [PubMed] [Google Scholar]
  18. Baldwin G. C., Fleischmann J., Chung Y., Koyanagi Y., Chen I. S., Golde D. W. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc Natl Acad Sci U S A. 1990 May;87(10):3933–3937. doi: 10.1073/pnas.87.10.3933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Banda N. K., Bernier J., Kurahara D. K., Kurrle R., Haigwood N., Sekaly R. P., Finkel T. H. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med. 1992 Oct 1;176(4):1099–1106. doi: 10.1084/jem.176.4.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Bank I., Chess L. Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med. 1985 Oct 1;162(4):1294–1303. doi: 10.1084/jem.162.4.1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bansal A. S., Green L. M., Khoo S. H., Pumphrey R. S., Haeney M. R., Mandal B. K. HIV induces deletion of T cell receptor variable gene product-specific T cells. Clin Exp Immunol. 1993 Oct;94(1):17–20. doi: 10.1111/j.1365-2249.1993.tb05970.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bansal A. S., Green L. M., Pumphrey R. S., Mandal B. T cells, V genes, and HIV. Lancet. 1992 Jun 27;339(8809):1604–1604. doi: 10.1016/0140-6736(92)91865-6. [DOI] [PubMed] [Google Scholar]
  23. Benkirane M., Hirn M., Carrière D., Devaux C. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J Virol. 1995 Nov;69(11):6898–6903. doi: 10.1128/jvi.69.11.6898-6903.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Benkirane M., Jeang K. T., Devaux C. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J. 1994 Dec 1;13(23):5559–5569. doi: 10.1002/j.1460-2075.1994.tb06893.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Benkirane M., Schmid-Antomarchi H., Littman D. R., Hirn M., Rossi B., Devaux C. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J Virol. 1995 Nov;69(11):6904–6910. doi: 10.1128/jvi.69.11.6904-6910.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Benos D. J., McPherson S., Hahn B. H., Chaikin M. A., Benveniste E. N. Cytokines and HIV envelope glycoprotein gp120 stimulate Na+/H+ exchange in astrocytes. J Biol Chem. 1994 May 13;269(19):13811–13816. [PubMed] [Google Scholar]
  27. Berberian L., Goodglick L., Kipps T. J., Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science. 1993 Sep 17;261(5128):1588–1591. doi: 10.1126/science.7690497. [DOI] [PubMed] [Google Scholar]
  28. Berger E. A., Lifson J. D., Eiden L. E. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082–8086. doi: 10.1073/pnas.88.18.8082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bernstein H. B., Tucker S. P., Hunter E., Schutzbach J. S., Compans R. W. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J Virol. 1994 Jan;68(1):463–468. doi: 10.1128/jvi.68.1.463-468.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Bernstein L. J., Ochs H. D., Wedgwood R. J., Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr. 1985 Sep;107(3):352–357. doi: 10.1016/s0022-3476(85)80505-9. [DOI] [PubMed] [Google Scholar]
  31. Bhat S., Spitalnik S. L., Gonzalez-Scarano F., Silberberg D. H. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7131–7134. doi: 10.1073/pnas.88.16.7131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Birx D. L., Redfield R. R., Tencer K., Fowler A., Burke D. S., Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood. 1990 Dec 1;76(11):2303–2310. [PubMed] [Google Scholar]
  33. Bisset L. R., Fierz W. Areas of sequence homology between several staphylococcal exotoxin "superantigens" and the HIV-1 pol protein. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1543–1544. doi: 10.1089/aid.1992.8.1543. [DOI] [PubMed] [Google Scholar]
  34. Bonyhadi M. L., Rabin L., Salimi S., Brown D. A., Kosek J., McCune J. M., Kaneshima H. HIV induces thymus depletion in vivo. Nature. 1993 Jun 24;363(6431):728–732. doi: 10.1038/363728a0. [DOI] [PubMed] [Google Scholar]
  35. Borghi P., Fantuzzi L., Varano B., Gessani S., Puddu P., Conti L., Capobianchi M. R., Ameglio F., Belardelli F. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J Virol. 1995 Feb;69(2):1284–1287. doi: 10.1128/jvi.69.2.1284-1287.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Boue F., Wallon C., Goujard C., Barre-Sinoussi F., Galanaud P., Delfraissy J. F. HIV induces IL-6 production by human B lymphocytes. Role of IL-4. J Immunol. 1992 Jun 15;148(12):3761–3767. [PubMed] [Google Scholar]
  37. Bour S., Geleziunas R., Wainberg M. A. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol Rev. 1995 Mar;59(1):63–93. doi: 10.1128/mr.59.1.63-93.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Boyer V., Desgranges C., Trabaud M. A., Fischer E., Kazatchkine M. D. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med. 1991 May 1;173(5):1151–1158. doi: 10.1084/jem.173.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Boyer V., Smith L. R., Ferre F., Pezzoli P., Trauger R. J., Jensen F. C., Carlo D. J. T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletion. Clin Exp Immunol. 1993 Jun;92(3):437–441. doi: 10.1111/j.1365-2249.1993.tb03417.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Breen E. C., Rezai A. R., Nakajima K., Beall G. N., Mitsuyasu R. T., Hirano T., Kishimoto T., Martinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol. 1990 Jan 15;144(2):480–484. [PubMed] [Google Scholar]
  41. Brenneman D. E., McCune S. K., Mervis R. F., Hill J. M. gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems. Adv Neuroimmunol. 1994;4(3):157–165. doi: 10.1016/s0960-5428(06)80252-4. [DOI] [PubMed] [Google Scholar]
  42. Brenneman D. E., Westbrook G. L., Fitzgerald S. P., Ennist D. L., Elkins K. L., Ruff M. R., Pert C. B. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature. 1988 Oct 13;335(6191):639–642. doi: 10.1038/335639a0. [DOI] [PubMed] [Google Scholar]
  43. Broder C. C., Nussbaum O., Gutheil W. G., Bachovchin W. W., Berger E. A. CD26 antigen and HIV fusion? Science. 1994 May 20;264(5162):1156–1165. doi: 10.1126/science.7909959. [DOI] [PubMed] [Google Scholar]
  44. Brodsky M. H., Warton M., Myers R. M., Littman D. R. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol. 1990 Apr 15;144(8):3078–3086. [PubMed] [Google Scholar]
  45. Bröker B. M., Tsygankov A. Y., Fickenscher H., Chitaev N. A., Müller-Fleckenstein I., Fleckenstein B., Bolen J. B., Emmrich F., Schulze-Koops H. Engagement of the CD4 receptor inhibits the interleukin-2-dependent proliferation of human T cells transformed by Herpesvirus saimiri. Eur J Immunol. 1994 Apr;24(4):843–850. doi: 10.1002/eji.1830240411. [DOI] [PubMed] [Google Scholar]
  46. Callebaut C., Krust B., Jacotot E., Hovanessian A. G. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science. 1993 Dec 24;262(5142):2045–2050. doi: 10.1126/science.7903479. [DOI] [PubMed] [Google Scholar]
  47. Cambier J. C. Transmembrane signaling in T lymphocyte dependent B lymphocyte activation. Semin Immunol. 1989 Sep;1(1):43–54. [PubMed] [Google Scholar]
  48. Cameron P. U., Freudenthal P. S., Barker J. M., Gezelter S., Inaba K., Steinman R. M. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992 Jul 17;257(5068):383–387. doi: 10.1126/science.1352913. [DOI] [PubMed] [Google Scholar]
  49. Capon D. J., Ward R. H. The CD4-gp120 interaction and AIDS pathogenesis. Annu Rev Immunol. 1991;9:649–678. doi: 10.1146/annurev.iy.09.040191.003245. [DOI] [PubMed] [Google Scholar]
  50. Cayota A., Vuillier F., Siciliano J., Dighiero G. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1 infected patients. Int Immunol. 1994 Apr;6(4):611–621. doi: 10.1093/intimm/6.4.611. [DOI] [PubMed] [Google Scholar]
  51. Cefai D., Debre P., Kaczorek M., Idziorek T., Autran B., Bismuth G. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway. J Clin Invest. 1990 Dec;86(6):2117–2124. doi: 10.1172/JCI114950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Cefai D., Ferrer M., Serpente N., Idziorek T., Dautry-Varsat A., Debre P., Bismuth G. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol. 1992 Jul 1;149(1):285–294. [PubMed] [Google Scholar]
  53. Chanh T. C., Kennedy R. C., Kanda P. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cell Immunol. 1988 Jan;111(1):77–86. doi: 10.1016/0008-8749(88)90052-4. [DOI] [PubMed] [Google Scholar]
  54. Chehimi J., Starr S. E., Frank I., D'Andrea A., Ma X., MacGregor R. R., Sennelier J., Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med. 1994 Apr 1;179(4):1361–1366. doi: 10.1084/jem.179.4.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Chehimi J., Trinchieri G. Interleukin-12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J Clin Immunol. 1994 May;14(3):149–161. doi: 10.1007/BF01533364. [DOI] [PubMed] [Google Scholar]
  56. Cheng-Mayer C., Rutka J. T., Rosenblum M. L., McHugh T., Stites D. P., Levy J. A. Human immunodeficiency virus can productively infect cultured human glial cells. Proc Natl Acad Sci U S A. 1987 May;84(10):3526–3530. doi: 10.1073/pnas.84.10.3526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Chiodi F., Fuerstenberg S., Gidlund M., Asjö B., Fenyö E. M. Infection of brain-derived cells with the human immunodeficiency virus. J Virol. 1987 Apr;61(4):1244–1247. doi: 10.1128/jvi.61.4.1244-1247.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Chirmule N., Goonewardena H., Pahwa S., Pasieka R., Kalyanaraman V. S., Pahwa S. HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells. J Biol Chem. 1995 Aug 18;270(33):19364–19369. doi: 10.1074/jbc.270.33.19364. [DOI] [PubMed] [Google Scholar]
  59. Chirmule N., Kalyanaraman V. S., Lederman S., Oyaizu N., Yagura H., Yellin M. J., Chess L., Pahwa S. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. J Immunol. 1993 Mar 15;150(6):2478–2486. [PubMed] [Google Scholar]
  60. Chirmule N., Kalyanaraman V. S., Oyaizu N., Slade H. B., Pahwa S. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein GP120 of human immunodeficiency virus. Blood. 1990 Jan 1;75(1):152–159. [PubMed] [Google Scholar]
  61. Chirmule N., Kalyanaraman V. S., Pahwa S. Signals transduced through the CD4 molecule on T lymphocytes activate NF-kappa B. Biochem Biophys Res Commun. 1994 Aug 30;203(1):498–505. doi: 10.1006/bbrc.1994.2210. [DOI] [PubMed] [Google Scholar]
  62. Chirmule N., Kalyanaraman V. S., Saxinger C., Wong-Staal F., Ghrayeb J., Pahwa S. Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41. AIDS Res Hum Retroviruses. 1990 Mar;6(3):299–305. doi: 10.1089/aid.1990.6.299. [DOI] [PubMed] [Google Scholar]
  63. Chirmule N., Kalyanaraman V. S., Slade H., Oyaizu N., Pahwa S. Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells. Clin Exp Immunol. 1990 May;80(2):161–166. doi: 10.1111/j.1365-2249.1990.tb05226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Chirmule N., Kalyanaraman V., Oyaizu N., Pahwa S. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J Acquir Immune Defic Syndr. 1988;1(5):425–430. [PubMed] [Google Scholar]
  65. Chirmule N., McCloskey T. W., Hu R., Kalyanaraman V. S., Pahwa S. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J Immunol. 1995 Jul 15;155(2):917–924. [PubMed] [Google Scholar]
  66. Chirmule N., Oyaizu N., Kalyanaraman V. S., Pahwa S. Inhibition of normal B-cell function by human immunodeficiency virus envelope glycoprotein, gp120. Blood. 1992 Mar 1;79(5):1245–1254. [PubMed] [Google Scholar]
  67. Chirmule N., Oyaizu N., Saxinger C., Pahwa S. Nef protein of HIV-1 has B-cell stimulatory activity. AIDS. 1994 Jun;8(6):733–734. doi: 10.1097/00002030-199406000-00002. [DOI] [PubMed] [Google Scholar]
  68. Chirmule N., Wang X. P., Hu R., Oyaizu N., Roifman C., Pahwa R., Kalyanaraman V. S., Pahwa S. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help. Cell Immunol. 1994 Apr 15;155(1):169–182. doi: 10.1006/cimm.1994.1110. [DOI] [PubMed] [Google Scholar]
  69. Chuck R. S., Cantor C. R., Tse D. B. Effect of CD4 engagement on CD4-T cell receptor complexes. Cell Immunol. 1993 Nov;152(1):211–219. doi: 10.1006/cimm.1993.1280. [DOI] [PubMed] [Google Scholar]
  70. Chuvpilo S., Schomberg C., Gerwig R., Heinfling A., Reeves R., Grummt F., Serfling E. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin-4 promoter. Nucleic Acids Res. 1993 Dec 11;21(24):5694–5704. doi: 10.1093/nar/21.24.5694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 1985 Oct 25;230(4724):453–455. doi: 10.1126/science.2996136. [DOI] [PubMed] [Google Scholar]
  72. Clark S. J., Jefferies W. A., Barclay A. N., Gagnon J., Williams A. F. Peptide and nucleotide sequences of rat CD4 (W3/25) antigen: evidence for derivation from a structure with four immunoglobulin-related domains. Proc Natl Acad Sci U S A. 1987 Mar;84(6):1649–1653. doi: 10.1073/pnas.84.6.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Clayton L. K., Hussey R. E., Steinbrich R., Ramachandran H., Husain Y., Reinherz E. L. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature. 1988 Sep 22;335(6188):363–366. doi: 10.1038/335363a0. [DOI] [PubMed] [Google Scholar]
  74. Clayton L. K., Sieh M., Pious D. A., Reinherz E. L. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature. 1989 Jun 15;339(6225):548–551. doi: 10.1038/339548a0. [DOI] [PubMed] [Google Scholar]
  75. Clerici M., Hakim F. T., Venzon D. J., Blatt S., Hendrix C. W., Wynn T. A., Shearer G. M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest. 1993 Mar;91(3):759–765. doi: 10.1172/JCI116294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Clerici M., Lucey D. R., Berzofsky J. A., Pinto L. A., Wynn T. A., Blatt S. P., Dolan M. J., Hendrix C. W., Wolf S. F., Shearer G. M. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science. 1993 Dec 10;262(5140):1721–1724. doi: 10.1126/science.7903123. [DOI] [PubMed] [Google Scholar]
  77. Clerici M., Sarin A., Coffman R. L., Wynn T. A., Blatt S. P., Hendrix C. W., Wolf S. F., Shearer G. M., Henkart P. A. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11811–11815. doi: 10.1073/pnas.91.25.11811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Clerici M., Shearer G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994 Dec;15(12):575–581. doi: 10.1016/0167-5699(94)90220-8. [DOI] [PubMed] [Google Scholar]
  79. Clerici M., Wynn T. A., Berzofsky J. A., Blatt S. P., Hendrix C. W., Sher A., Coffman R. L., Shearer G. M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest. 1994 Feb;93(2):768–775. doi: 10.1172/JCI117031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Clouse K. A., Cosentino L. M., Weih K. A., Pyle S. W., Robbins P. B., Hochstein H. D., Natarajan V., Farrar W. L. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol. 1991 Nov 1;147(9):2892–2901. [PubMed] [Google Scholar]
  81. Cohen D. I., Tani Y., Tian H., Boone E., Samelson L. E., Lane H. C. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science. 1992 Apr 24;256(5056):542–545. doi: 10.1126/science.1570514. [DOI] [PubMed] [Google Scholar]
  82. Condon R., Colquhoun P., Plett R., De Vol D., Fletcher N. Work at sea: a study of sleep, and of circadian rhythms in physiological and psychological functions, in watchkeepers on merchant vessels. IV. Rhythms in performance and alertness. Int Arch Occup Environ Health. 1988;60(6):405–411. doi: 10.1007/BF00381387. [DOI] [PubMed] [Google Scholar]
  83. Corado J., Mazerolles F., Le Deist F., Barbat C., Kaczorek M., Fischer A. Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160. J Immunol. 1991 Jul 15;147(2):475–482. [PubMed] [Google Scholar]
  84. Corbeil J., Richman D. D. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells. J Gen Virol. 1995 Mar;76(Pt 3):681–690. doi: 10.1099/0022-1317-76-3-681. [DOI] [PubMed] [Google Scholar]
  85. Cordiali P., Balzarotti V., Morante S., Parisi V., Pugliese O., Camponeschi B., Colizzi V. Convergent evolution in the homology between HIV gp160 and HLA class II molecules. AIDS Res Hum Retroviruses. 1992 Sep;8(9):1561–1565. doi: 10.1089/aid.1992.8.1561. [DOI] [PubMed] [Google Scholar]
  86. Courgnaud V., Lauré F., Brossard A., Bignozzi C., Goudeau A., Barin F., Bréchot C. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses. 1991 Mar;7(3):337–341. doi: 10.1089/aid.1991.7.337. [DOI] [PubMed] [Google Scholar]
  87. Crise B., Rose J. K. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J Virol. 1992 Apr;66(4):2296–2301. doi: 10.1128/jvi.66.4.2296-2301.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Crispe I. N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity. 1994 Aug;1(5):347–349. doi: 10.1016/1074-7613(94)90064-7. [DOI] [PubMed] [Google Scholar]
  89. Dadaglio G., Garcia S., Montagnier L., Gougeon M. L. Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals. J Exp Med. 1994 Feb 1;179(2):413–424. doi: 10.1084/jem.179.2.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  91. Dalgleish A. G., Colizzi V. Role of major histocompatibility complex recognition in the protection and immunopathogenesis of AIDS. Joint Anglo-Italian Workshop on Ponza Island, Italy. AIDS. 1992 May;6(5):523–525. doi: 10.1097/00002030-199205000-00020. [DOI] [PubMed] [Google Scholar]
  92. Dalgleish A. G., Wilson S., Gompels M., Ludlam C., Gazzard B., Coates A. M., Habeshaw J. T-cell receptor variable gene products and early HIV-1 infection. Lancet. 1992 Apr 4;339(8797):824–828. doi: 10.1016/0140-6736(92)90277-a. [DOI] [PubMed] [Google Scholar]
  93. Daniel V., Schimpf K., Opelz G. Lymphocyte autoantibodies and alloantibodies in HIV-positive haemophilia patients. Clin Exp Immunol. 1989 Feb;75(2):178–183. [PMC free article] [PubMed] [Google Scholar]
  94. Daniel V., Süsal C., Weimer R., Zimmermann R., Huth-Kühne A., Opelz G. Association of T cell and macrophage dysfunction with surface gp 120-immunoglobulin-complement complexes in HIV-infected patients. Clin Exp Immunol. 1993 Aug;93(2):152–156. doi: 10.1111/j.1365-2249.1993.tb07958.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Davis B. R., Schwartz D. H., Marx J. C., Johnson C. E., Berry J. M., Lyding J., Merigan T. C., Zander A. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol. 1991 Apr;65(4):1985–1990. doi: 10.1128/jvi.65.4.1985-1990.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Dawson V. L., Dawson T. M., Uhl G. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3256–3259. doi: 10.1073/pnas.90.8.3256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. De Rossi A., Calabro M. L., Panozzo M., Bernardi D., Caruso B., Tridente G., Chieco-Bianchi L. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses. 1990 Mar;6(3):287–298. doi: 10.1089/aid.1990.6.287. [DOI] [PubMed] [Google Scholar]
  98. Dhein J., Walczak H., Bäumler C., Debatin K. M., Krammer P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) Nature. 1995 Feb 2;373(6513):438–441. doi: 10.1038/373438a0. [DOI] [PubMed] [Google Scholar]
  99. Diamond D. C., Sleckman B. P., Gregory T., Lasky L. A., Greenstein J. L., Burakoff S. J. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. J Immunol. 1988 Dec 1;141(11):3715–3717. [PubMed] [Google Scholar]
  100. Dianzani U., Bragardo M., Buonfiglio D., Redoglia V., Funaro A., Portoles P., Rojo J., Malavasi F., Pileri A. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Eur J Immunol. 1995 May;25(5):1306–1311. doi: 10.1002/eji.1830250526. [DOI] [PubMed] [Google Scholar]
  101. Dianzani U., Shaw A., Fernandez-Cabezudo M., Janeway C. A., Jr Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen. Int Immunol. 1992 Sep;4(9):995–1001. doi: 10.1093/intimm/4.9.995. [DOI] [PubMed] [Google Scholar]
  102. Dierich M. P., Ebenbichler C. F., Marschang P., Füst G., Thielens N. M., Arlaud G. J. HIV and human complement: mechanisms of interaction and biological implication. Immunol Today. 1993 Sep;14(9):435–440. doi: 10.1016/0167-5699(93)90246-H. [DOI] [PubMed] [Google Scholar]
  103. Dobrescu D., Ursea B., Pope M., Asch A. S., Posnett D. N. Enhanced HIV-1 replication in V beta 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen. Cell. 1995 Sep 8;82(5):753–763. doi: 10.1016/0092-8674(95)90472-7. [DOI] [PubMed] [Google Scholar]
  104. Donahue R. E., Johnson M. M., Zon L. I., Clark S. C., Groopman J. E. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature. 1987 Mar 12;326(6109):200–203. doi: 10.1038/326200a0. [DOI] [PubMed] [Google Scholar]
  105. Drake C. G., Kotzin B. L. Superantigens: biology, immunology, and potential role in disease. J Clin Immunol. 1992 May;12(3):149–162. doi: 10.1007/BF00918083. [DOI] [PubMed] [Google Scholar]
  106. Dreyer E. B., Kaiser P. K., Offermann J. T., Lipton S. A. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990 Apr 20;248(4953):364–367. doi: 10.1126/science.2326646. [DOI] [PubMed] [Google Scholar]
  107. Dürrbaum-Landmann I., Kaltenhäuser E., Flad H. D., Ernst M. HIV-1 envelope protein gp120 affects phenotype and function of monocytes in vitro. J Leukoc Biol. 1994 Apr;55(4):545–551. doi: 10.1002/jlb.55.4.545. [DOI] [PubMed] [Google Scholar]
  108. Dürrbaum-Landmann I., Kaltenhäuser E., Flad H. D., Ernst M. HIV-1 envelope protein gp120 affects phenotype and function of monocytes in vitro. J Leukoc Biol. 1994 Apr;55(4):545–551. doi: 10.1002/jlb.55.4.545. [DOI] [PubMed] [Google Scholar]
  109. Ebenbichler C. F., Thielens N. M., Vornhagen R., Marschang P., Arlaud G. J., Dierich M. P. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med. 1991 Dec 1;174(6):1417–1424. doi: 10.1084/jem.174.6.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Ehrenreich H., Rieckmann P., Sinowatz F., Weih K. A., Arthur L. O., Goebel F. D., Burd P. R., Coligan J. E., Clouse K. A. Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol. 1993 May 15;150(10):4601–4609. [PubMed] [Google Scholar]
  111. Eiden L. E., Lifson J. D. HIV interactions with CD4: a continuum of conformations and consequences. Immunol Today. 1992 Jun;13(6):201–206. doi: 10.1016/0167-5699(92)90154-Y. [DOI] [PubMed] [Google Scholar]
  112. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993 Mar 25;362(6418):359–362. doi: 10.1038/362359a0. [DOI] [PubMed] [Google Scholar]
  113. Emilie D., Fior R., Jarrousse B., Marfaing-Koka A., Merrien D., Devergne O., Crevon M. C., Maillot M. C., Galanaud P. Cytokines in HIV infection. Int J Immunopharmacol. 1994 May-Jun;16(5-6):391–396. doi: 10.1016/0192-0561(94)90026-4. [DOI] [PubMed] [Google Scholar]
  114. Ennen J., Seipp I., Norley S. G., Kurth R. Decreased accessory cell function of macrophages after infection with human immunodeficiency virus type 1 in vitro. Eur J Immunol. 1990 Nov;20(11):2451–2456. doi: 10.1002/eji.1830201114. [DOI] [PubMed] [Google Scholar]
  115. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993 May;33(5):429–436. doi: 10.1002/ana.410330502. [DOI] [PubMed] [Google Scholar]
  116. Estaquier J., Idziorek T., de Bels F., Barré-Sinoussi F., Hurtrel B., Aubertin A. M., Venet A., Mehtali M., Muchmore E., Michel P. Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9431–9435. doi: 10.1073/pnas.91.20.9431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Fahey J. L., Prince H., Weaver M., Groopman J., Visscher B., Schwartz K., Detels R. Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med. 1984 Jan;76(1):95–100. doi: 10.1016/0002-9343(84)90756-3. [DOI] [PubMed] [Google Scholar]
  118. Fan J., Bass H. Z., Fahey J. L. Elevated IFN-gamma and decreased IL-2 gene expression are associated with HIV infection. J Immunol. 1993 Nov 1;151(9):5031–5040. [PubMed] [Google Scholar]
  119. Fauci A. S. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science. 1988 Feb 5;239(4840):617–622. doi: 10.1126/science.3277274. [DOI] [PubMed] [Google Scholar]
  120. Fennie C., Lasky L. A. Model for intracellular folding of the human immunodeficiency virus type 1 gp120. J Virol. 1989 Feb;63(2):639–646. doi: 10.1128/jvi.63.2.639-646.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Field E. H., Rouse T. M., Fleming A. L., Jamali I., Cowdery J. S. Altered IFN-gamma and IL-4 pattern lymphokine secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody. J Immunol. 1992 Aug 15;149(4):1131–1137. [PubMed] [Google Scholar]
  122. Fields A. P., Bednarik D. P., Hess A., May W. S. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature. 1988 May 19;333(6170):278–280. doi: 10.1038/333278a0. [DOI] [PubMed] [Google Scholar]
  123. Finkel T. H., Banda N. K. Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells? Curr Opin Immunol. 1994 Aug;6(4):605–615. doi: 10.1016/0952-7915(94)90149-x. [DOI] [PubMed] [Google Scholar]
  124. Finkel T. H., Tudor-Williams G., Banda N. K., Cotton M. F., Curiel T., Monks C., Baba T. W., Ruprecht R. M., Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat Med. 1995 Feb;1(2):129–134. doi: 10.1038/nm0295-129. [DOI] [PubMed] [Google Scholar]
  125. Fleury S., Lamarre D., Meloche S., Ryu S. E., Cantin C., Hendrickson W. A., Sekaly R. P. Mutational analysis of the interaction between CD4 and class II MHC: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell. 1991 Sep 6;66(5):1037–1049. doi: 10.1016/0092-8674(91)90447-7. [DOI] [PubMed] [Google Scholar]
  126. Folks T. M. Human immunodeficiency virus in bone marrow: still more questions than answers. Blood. 1991 Apr 15;77(8):1625–1626. [PubMed] [Google Scholar]
  127. Folks T. M., Kessler S. W., Orenstein J. M., Justement J. S., Jaffe E. S., Fauci A. S. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science. 1988 Nov 11;242(4880):919–922. doi: 10.1126/science.2460922. [DOI] [PubMed] [Google Scholar]
  128. Forte P., Aiuti A., Pozzi L., Citarella F., Fattorossi A., Rossi G. B., Fantoni A. Human CD4 produced in lymphoid cells of transgenic mice binds HIV gp120 and modifies the subsets of mouse T-cell populations. Immunogenetics. 1993;38(6):455–459. doi: 10.1007/BF00184528. [DOI] [PubMed] [Google Scholar]
  129. Foster S., Beverley P., Aspinall R. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor. Eur J Immunol. 1995 Jun;25(6):1778–1782. doi: 10.1002/eji.1830250644. [DOI] [PubMed] [Google Scholar]
  130. Francis M. L., Meltzer M. S. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J Immunol. 1993 Aug 15;151(4):2208–2216. [PubMed] [Google Scholar]
  131. Freed E. O., Martin M. A. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection. J Biol Chem. 1995 Oct 13;270(41):23883–23886. doi: 10.1074/jbc.270.41.23883. [DOI] [PubMed] [Google Scholar]
  132. Füst G., Dierich M. P., Hidvégi T. Role of humoral factors in the progression of HIV disease. Immunol Today. 1995 Apr;16(4):167–169. doi: 10.1016/0167-5699(95)80114-6. [DOI] [PubMed] [Google Scholar]
  133. Gartner S., Markovits P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986 Jul 11;233(4760):215–219. doi: 10.1126/science.3014648. [DOI] [PubMed] [Google Scholar]
  134. Gaulton G. N., Brass L. F., Kozbor D., Pletcher C. H., Hoxie J. A. Inhibition of T cell antigen receptor-dependent phosphorylation of CD4 in human immunodeficiency virus type 1 infected cells. J Biol Chem. 1992 Feb 25;267(6):4102–4109. [PubMed] [Google Scholar]
  135. Gendelman H. E., Friedman R. M., Joe S., Baca L. M., Turpin J. A., Dveksler G., Meltzer M. S., Dieffenbach C. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes. J Exp Med. 1990 Nov 1;172(5):1433–1442. doi: 10.1084/jem.172.5.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Gessani S., Puddu P., Varano B., Borghi P., Conti L., Fantuzzi L., Belardelli F. Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J Virol. 1994 Mar;68(3):1983–1986. doi: 10.1128/jvi.68.3.1983-1986.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Gibellini D., Zauli G., Re M. C., Furlini G., Lolli S., Borgatti P., Capitani S., La Placa M. CD4 engagement by HIV-1 in TF-1 hematopoietic progenitor cells increases protein kinase C activity and reduces intracellular Ca2+ levels. New Microbiol. 1994 Apr;17(2):85–92. [PubMed] [Google Scholar]
  138. Gill H. S., Watson D. L., Brandon M. R. In vivo inhibition by a monoclonal antibody to CD4+ T cells of humoral and cellular immunity in sheep. Immunology. 1992 Sep;77(1):38–42. [PMC free article] [PubMed] [Google Scholar]
  139. Giulian D., Wendt E., Vaca K., Noonan C. A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2769–2773. doi: 10.1073/pnas.90.7.2769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Glaichenhaus N., Shastri N., Littman D. R., Turner J. M. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell. 1991 Feb 8;64(3):511–520. doi: 10.1016/0092-8674(91)90235-q. [DOI] [PubMed] [Google Scholar]
  141. Go C., Miller J. Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J Exp Med. 1992 May 1;175(5):1327–1336. doi: 10.1084/jem.175.5.1327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Golding H., Robey F. A., Gates F. T., 3rd, Linder W., Beining P. R., Hoffman T., Golding B. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med. 1988 Mar 1;167(3):914–923. doi: 10.1084/jem.167.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Golding H., Shearer G. M., Hillman K., Lucas P., Manischewitz J., Zajac R. A., Clerici M., Gress R. E., Boswell R. N., Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest. 1989 Apr;83(4):1430–1435. doi: 10.1172/JCI114034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Goldman F., Jensen W. A., Johnson G. L., Heasley L., Cambier J. C. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J Immunol. 1994 Oct 1;153(7):2905–2917. [PubMed] [Google Scholar]
  145. Goudsmit J., Back N. K., Nara P. L. Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB J. 1991 Jul;5(10):2427–2436. doi: 10.1096/fasebj.5.10.2065891. [DOI] [PubMed] [Google Scholar]
  146. Gougeon M. L., Dadaglio G., Garcia S., Müller-Alouf H., Roue R., Montagnier L. Is a dominant superantigen involved in AIDS pathogenesis? Lancet. 1993 Jul 3;342(8862):50–51. doi: 10.1016/0140-6736(93)91914-8. [DOI] [PubMed] [Google Scholar]
  147. Gougeon M. L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C., Montagnier L. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses. 1993 Jun;9(6):553–563. doi: 10.1089/aid.1993.9.553. [DOI] [PubMed] [Google Scholar]
  148. Graziosi C., Pantaleo G., Gantt K. R., Fortin J. P., Demarest J. F., Cohen O. J., Sékaly R. P., Fauci A. S. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science. 1994 Jul 8;265(5169):248–252. doi: 10.1126/science.8023143. [DOI] [PubMed] [Google Scholar]
  149. Griscelli C., Lisowska-Grospierre B., Mach B. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic Rev. 1989;1(2):135–153. [PubMed] [Google Scholar]
  150. Groenink M., Fouchier R. A., Broersen S., Baker C. H., Koot M., van't Wout A. B., Huisman H. G., Miedema F., Tersmette M., Schuitemaker H. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science. 1993 Jun 4;260(5113):1513–1516. doi: 10.1126/science.8502996. [DOI] [PubMed] [Google Scholar]
  151. Groux H., Torpier G., Monté D., Mouton Y., Capron A., Ameisen J. C. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med. 1992 Feb 1;175(2):331–340. doi: 10.1084/jem.175.2.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Grusby M. J., Johnson R. S., Papaioannou V. E., Glimcher L. H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 1991 Sep 20;253(5026):1417–1420. doi: 10.1126/science.1910207. [DOI] [PubMed] [Google Scholar]
  153. Guo H. G., Veronese F. M., Tschachler E., Pal R., Kalyanaraman V. S., Gallo R. C., Reitz M. S., Jr Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage. Virology. 1990 Jan;174(1):217–224. doi: 10.1016/0042-6822(90)90070-8. [DOI] [PubMed] [Google Scholar]
  154. Gupta S., Aggarwal S., Kim C., Gollapudi S. Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report. Int J Immunopharmacol. 1994 Mar;16(3):197–204. doi: 10.1016/0192-0561(94)90013-2. [DOI] [PubMed] [Google Scholar]
  155. Gupta S. Signal transduction defect in the acquired immunodeficiency syndrome and AIDS-related complex. Thymus. 1993 Sep;22(2):83–90. [PubMed] [Google Scholar]
  156. Gupta S., Vayuvegula B. Human immunodeficiency virus-associated changes in signal transduction. J Clin Immunol. 1987 Nov;7(6):486–489. doi: 10.1007/BF00915060. [DOI] [PubMed] [Google Scholar]
  157. Gurley R. J., Ikeuchi K., Byrn R. A., Anderson K., Groopman J. E. CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1993–1997. doi: 10.1073/pnas.86.6.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Gurram M., Chirmule N., Wang X. P., Ponugoti N., Pahwa S. Increased spontaneous secretion of interleukin 6 and tumor necrosis factor alpha by peripheral blood lymphocytes of human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1994 Jun;13(6):496–501. doi: 10.1097/00006454-199406000-00006. [DOI] [PubMed] [Google Scholar]
  159. Habeshaw J. A., Dalgleish A. G., Bountiff L., Newell A. L., Wilks D., Walker L. C., Manca F. AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today. 1990 Nov;11(11):418–425. doi: 10.1016/0167-5699(90)90162-3. [DOI] [PubMed] [Google Scholar]
  160. Harouse J. M., Bhat S., Spitalnik S. L., Laughlin M., Stefano K., Silberberg D. H., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 1991 Jul 19;253(5017):320–323. doi: 10.1126/science.1857969. [DOI] [PubMed] [Google Scholar]
  161. Harrell R. A., Cianciolo G. J., Copeland T. D., Oroszlan S., Snyderman R. Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. J Immunol. 1986 May 15;136(10):3517–3520. [PubMed] [Google Scholar]
  162. Haughn L., Gratton S., Caron L., Sékaly R. P., Veillette A., Julius M. Association of tyrosine kinase p56lck with CD4 inhibits the induction of growth through the alpha beta T-cell receptor. Nature. 1992 Jul 23;358(6384):328–331. doi: 10.1038/358328a0. [DOI] [PubMed] [Google Scholar]
  163. Haurum J. S., Thiel S., Jones I. M., Fischer P. B., Laursen S. B., Jensenius J. C. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS. 1993 Oct;7(10):1307–1313. doi: 10.1097/00002030-199310000-00002. [DOI] [PubMed] [Google Scholar]
  164. Haynes B. F. Scientific and social issues of human immunodeficiency virus vaccine development. Science. 1993 May 28;260(5112):1279–1286. doi: 10.1126/science.8493572. [DOI] [PubMed] [Google Scholar]
  165. Hays E. F., Uittenbogaart C. H., Brewer J. C., Vollger L. W., Zack J. A. In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS. 1992 Mar;6(3):265–272. doi: 10.1097/00002030-199203000-00003. [DOI] [PubMed] [Google Scholar]
  166. Heyes M. P., Saito K., Markey S. P. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J. 1992 May 1;283(Pt 3):633–635. doi: 10.1042/bj2830633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Hivroz C., Mazerolles F., Soula M., Fagard R., Graton S., Meloche S., Sekaly R. P., Fischer A. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes. Eur J Immunol. 1993 Mar;23(3):600–607. doi: 10.1002/eji.1830230303. [DOI] [PubMed] [Google Scholar]
  168. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995 Jan 12;373(6510):123–126. doi: 10.1038/373123a0. [DOI] [PubMed] [Google Scholar]
  169. Hodara V. L., Jeddi-Tehrani M., Grunewald J., Andersson R., Scarlatti G., Esin S., Holmberg V., Libonatti O., Wigzell H. HIV infection leads to differential expression of T-cell receptor V beta genes in CD4+ and CD8+ T cells. AIDS. 1993 May;7(5):633–638. doi: 10.1097/00002030-199305000-00004. [DOI] [PubMed] [Google Scholar]
  170. Hofmann B., Nishanian P., Nguyen T., Insixiengmay P., Fahey J. L. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6676–6680. doi: 10.1073/pnas.90.14.6676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Hofmann B., Nishanian P., Nguyen T., Liu M., Fahey J. L. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 1993 May;7(5):659–664. doi: 10.1097/00002030-199305000-00008. [DOI] [PubMed] [Google Scholar]
  172. Horneff G., Guse A. H., Schulze-Koops H., Kalden J. R., Burmester G. R., Emmrich F. Human CD4 modulation in vivo induced by antibody treatment. Clin Immunol Immunopathol. 1993 Jan;66(1):80–90. doi: 10.1006/clin.1993.1011. [DOI] [PubMed] [Google Scholar]
  173. Houlgatte R., Scarmato P., el Marhomy S., Martin M., Ostankovitch M., Lafosse S., Vervisch A., Auffray C., Platier-Tonneau D. HLA class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. J Immunol. 1994 May 1;152(9):4475–4488. [PubMed] [Google Scholar]
  174. Hu R., Oyaizu N., Kalyanaraman V. S., Pahwa S. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin Immunol Immunopathol. 1994 Nov;73(2):245–251. doi: 10.1006/clin.1994.1194. [DOI] [PubMed] [Google Scholar]
  175. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science. 1991 Jul 5;253(5015):71–74. doi: 10.1126/science.1905842. [DOI] [PubMed] [Google Scholar]
  176. Imberti L., Sottini A., Bettinardi A., Puoti M., Primi D. Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences. Science. 1991 Nov 8;254(5033):860–862. doi: 10.1126/science.1948066. [DOI] [PubMed] [Google Scholar]
  177. Jabado N., Le Deist F., Fisher A., Hivroz C. Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity. Eur J Immunol. 1994 Nov;24(11):2646–2652. doi: 10.1002/eji.1830241112. [DOI] [PubMed] [Google Scholar]
  178. Jameson B. A., Rao P. E., Kong L. I., Hahn B. H., Shaw G. M., Hood L. E., Kent S. B. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science. 1988 Jun 3;240(4857):1335–1339. doi: 10.1126/science.2453925. [DOI] [PubMed] [Google Scholar]
  179. Janeway C. A., Jr The co-receptor function of CD4. Semin Immunol. 1991 May;3(3):153–160. [PubMed] [Google Scholar]
  180. Janeway C. Immune recognition. Mls: makes a little sense. Nature. 1991 Feb 7;349(6309):459–461. doi: 10.1038/349459a0. [DOI] [PubMed] [Google Scholar]
  181. Jonker M., Slingerland W., Treacy G., van Eerd P., Pak K. Y., Wilson E., Tam S., Bakker K., Lobuglio A. F., Rieber P. In vivo treatment with a monoclonal chimeric anti-CD4 antibody results in prolonged depletion of circulating CD4+ cells in chimpanzees. Clin Exp Immunol. 1993 Sep;93(3):301–307. doi: 10.1111/j.1365-2249.1993.tb08176.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Juszczak R. J., Turchin H., Truneh A., Culp J., Kassis S. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with CD4 in human T lymphocytes. J Biol Chem. 1991 Jun 15;266(17):11176–11183. [PubMed] [Google Scholar]
  183. Kalams S. A., Johnson R. P., Trocha A. K., Dynan M. J., Ngo H. S., D'Aquila R. T., Kurnick J. T., Walker B. D. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med. 1994 Apr 1;179(4):1261–1271. doi: 10.1084/jem.179.4.1261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Kalyanaraman V. S., Rausch D. M., Osborne J., Padgett M., Hwang K. M., Lifson J. D., Eiden L. E. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation. J Immunol. 1990 Dec 15;145(12):4072–4078. [PubMed] [Google Scholar]
  185. Kaneshima H., Su L., Bonyhadi M. L., Connor R. I., Ho D. D., McCune J. M. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse. J Virol. 1994 Dec;68(12):8188–8192. doi: 10.1128/jvi.68.12.8188-8192.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Kang S. M., Beverly B., Tran A. C., Brorson K., Schwartz R. H., Lenardo M. J. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science. 1992 Aug 21;257(5073):1134–1138. doi: 10.1126/science.257.5073.1134. [DOI] [PubMed] [Google Scholar]
  187. Kanner S. B., Haffar O. K. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation. J Immunol. 1995 Mar 15;154(6):2996–3005. [PubMed] [Google Scholar]
  188. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 1992 May;6(8):2581–2590. doi: 10.1096/fasebj.6.8.1317309. [DOI] [PubMed] [Google Scholar]
  189. Katsikis P. D., Wunderlich E. S., Smith C. A., Herzenberg L. A., Herzenberg L. A. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med. 1995 Jun 1;181(6):2029–2036. doi: 10.1084/jem.181.6.2029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Kaufmann R., Laroche D., Buchner K., Hucho F., Rudd C., Lindschau C., Ludwig P., Höer A., Oberdisse E., Kopp J. The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction in T cells. J Acquir Immune Defic Syndr. 1992;5(8):760–770. [PubMed] [Google Scholar]
  191. Kekow J., Wachsman W., McCutchan J. A., Cronin M., Carson D. A., Lotz M. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8321–8325. doi: 10.1073/pnas.87.21.8321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Kido H., Fukutomi A., Katunuma N. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization. J Biol Chem. 1990 Dec 15;265(35):21979–21985. [PubMed] [Google Scholar]
  193. King L. B., Ashwell J. D. Signaling for death of lymphoid cells. Curr Opin Immunol. 1993 Jun;5(3):368–373. doi: 10.1016/0952-7915(93)90055-w. [DOI] [PubMed] [Google Scholar]
  194. Kion T. A., Hoffmann G. W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science. 1991 Sep 6;253(5024):1138–1140. doi: 10.1126/science.1909456. [DOI] [PubMed] [Google Scholar]
  195. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J. C., Montagnier L. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature. 1984 Dec 20;312(5996):767–768. doi: 10.1038/312767a0. [DOI] [PubMed] [Google Scholar]
  196. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  197. Koff W. C., Hoth D. F. Development and testing of AIDS vaccines. Science. 1988 Jul 22;241(4864):426–432. doi: 10.1126/science.3293212. [DOI] [PubMed] [Google Scholar]
  198. Koff W. C. The next steps toward a global AIDS vaccine. Science. 1994 Nov 25;266(5189):1335–1337. doi: 10.1126/science.7973724. [DOI] [PubMed] [Google Scholar]
  199. Koka P., He K., Zack J. A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S. S., Merrill J. E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med. 1995 Oct 1;182(4):941–951. doi: 10.1084/jem.182.4.941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Kollmann T. R., Kim A., Pettoello-Mantovani M., Hachamovitch M., Rubinstein A., Goldstein M. M., Goldstein H. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol. 1995 Jan 15;154(2):907–921. [PubMed] [Google Scholar]
  201. Kornfeld H., Cruikshank W. W., Pyle S. W., Berman J. S., Center D. M. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature. 1988 Sep 29;335(6189):445–448. doi: 10.1038/335445a0. [DOI] [PubMed] [Google Scholar]
  202. Krowka J., Stites D., Mills J., Hollander H., McHugh T., Busch M., Wilhelm L., Blackwood L. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus. Clin Exp Immunol. 1988 May;72(2):179–185. [PMC free article] [PubMed] [Google Scholar]
  203. Lacroix F., Zhao D. Y., Izaguirre C. A., Filion L. G. Suppression by HIV of IL-1 and IL-6 secretion in accessory cells: AC function defect partially corrected with exogenous IL-1 and IL-6. Clin Immunol Immunopathol. 1993 May;67(2):109–116. doi: 10.1006/clin.1993.1052. [DOI] [PubMed] [Google Scholar]
  204. Landau N. R., Warton M., Littman D. R. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature. 1988 Jul 14;334(6178):159–162. doi: 10.1038/334159a0. [DOI] [PubMed] [Google Scholar]
  205. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  206. Lane H. C., Masur H., Gelmann E. P., Longo D. L., Steis R. G., Chused T., Whalen G., Edgar L. C., Fauci A. S. Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):417–422. doi: 10.1016/0002-9343(85)90332-8. [DOI] [PubMed] [Google Scholar]
  207. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. doi: 10.1016/0092-8674(87)90524-1. [DOI] [PubMed] [Google Scholar]
  208. Lathey J. L., Agosti J. M., Nelson J. A., Corey L., Gregory S. A., Morrissey J. H., Edgington T. S., Oldstone M. B. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin Immunol Immunopathol. 1990 Jan;54(1):1–13. doi: 10.1016/0090-1229(90)90001-7. [DOI] [PubMed] [Google Scholar]
  209. Laurence J., Hodtsev A. S., Posnett D. N. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expression. Nature. 1992 Jul 16;358(6383):255–259. doi: 10.1038/358255a0. [DOI] [PubMed] [Google Scholar]
  210. Laurent-Crawford A. G., Krust B., Rivière Y., Desgranges C., Muller S., Kieny M. P., Dauguet C., Hovanessian A. G. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res Hum Retroviruses. 1993 Aug;9(8):761–773. doi: 10.1089/aid.1993.9.761. [DOI] [PubMed] [Google Scholar]
  211. Leahy D. J. A structural view of CD4 and CD8. FASEB J. 1995 Jan;9(1):17–25. doi: 10.1096/fasebj.9.1.7821755. [DOI] [PubMed] [Google Scholar]
  212. Lederman S., Yellin M. J., Krichevsky A., Belko J., Lee J. J., Chess L. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med. 1992 Apr 1;175(4):1091–1101. doi: 10.1084/jem.175.4.1091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  213. Lee M. R., Ho D. D., Gurney M. E. Functional interaction and partial homology between human immunodeficiency virus and neuroleukin. Science. 1987 Aug 28;237(4818):1047–1051. doi: 10.1126/science.3039662. [DOI] [PubMed] [Google Scholar]
  214. Lee S. C., Dickson D. W., Liu W., Brosnan C. F. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol. 1993 Jul;46(1-2):19–24. doi: 10.1016/0165-5728(93)90229-r. [DOI] [PubMed] [Google Scholar]
  215. Leiderman I. Z., Greenberg M. L., Adelsberg B. R., Siegal F. P. A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood. 1987 Nov;70(5):1267–1272. [PubMed] [Google Scholar]
  216. Letvin N. L. Vaccines against human immunodeficiency virus--progress and prospects. N Engl J Med. 1993 Nov 4;329(19):1400–1405. doi: 10.1056/NEJM199311043291908. [DOI] [PubMed] [Google Scholar]
  217. Levy J. A. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 1993 Mar;57(1):183–289. doi: 10.1128/mr.57.1.183-289.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Lewis D. E., Tang D. S., Adu-Oppong A., Schober W., Rodgers J. R. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J Immunol. 1994 Jul 1;153(1):412–420. [PubMed] [Google Scholar]
  219. Liegler T. J., Stites D. P. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr. 1994 Apr;7(4):340–348. [PubMed] [Google Scholar]
  220. Lifson J. D., Hwang K. M., Nara P. L., Fraser B., Padgett M., Dunlop N. M., Eiden L. E. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science. 1988 Aug 5;241(4866):712–716. doi: 10.1126/science.2969619. [DOI] [PubMed] [Google Scholar]
  221. Linette G. P., Hartzman R. J., Ledbetter J. A., June C. H. HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor. Science. 1988 Jul 29;241(4865):573–576. doi: 10.1126/science.2899908. [DOI] [PubMed] [Google Scholar]
  222. Lipton S. A. Memantine prevents HIV coat protein-induced neuronal injury in vitro. Neurology. 1992 Jul;42(7):1403–1405. doi: 10.1212/wnl.42.7.1403. [DOI] [PubMed] [Google Scholar]
  223. Littman D. R. The structure of the CD4 and CD8 genes. Annu Rev Immunol. 1987;5:561–584. doi: 10.1146/annurev.iy.05.040187.003021. [DOI] [PubMed] [Google Scholar]
  224. Lombardi V., Rossi P., Romiti L., Mattei M., Mariani F., Poccia F., Colizzi V. HIV gp120 epitope immunodominance in MRL/Ipr mice. AIDS Res Hum Retroviruses. 1992 Jun;8(6):1081–1082. doi: 10.1089/aid.1992.8.1081. [DOI] [PubMed] [Google Scholar]
  225. Lopalco L., De Santis C., Meneveri R., Longhi R., Ginelli E., Grassi F., Siccardi A. G., Beretta A. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain. Eur J Immunol. 1993 Aug;23(8):2016–2021. doi: 10.1002/eji.1830230844. [DOI] [PubMed] [Google Scholar]
  226. Louache F., Debili N., Marandin A., Coulombel L., Vainchenker W. Expression of CD4 by human hematopoietic progenitors. Blood. 1994 Nov 15;84(10):3344–3355. [PubMed] [Google Scholar]
  227. Lowe S. W., Schmitt E. M., Smith S. W., Osborne B. A., Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993 Apr 29;362(6423):847–849. doi: 10.1038/362847a0. [DOI] [PubMed] [Google Scholar]
  228. Lu Y. Y., Koga Y., Tanaka K., Sasaki M., Kimura G., Nomoto K. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J Virol. 1994 Jan;68(1):390–399. doi: 10.1128/jvi.68.1.390-399.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Lunardi-Iskandar Y., Georgoulias V., Vittecoq D., Nugeyre M. T., Ammar A., Clemenceau C., Barre-Sinoussi F., Chermann J. C., Schwartzenberg L., Jasmin C. Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2. Leuk Res. 1987;11(8):753–760. doi: 10.1016/0145-2126(87)90013-0. [DOI] [PubMed] [Google Scholar]
  230. Lund O., Hansen J., Søorensen A. M., Mosekilde E., Nielsen J. O., Hansen J. E. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infection. J Virol. 1995 Apr;69(4):2393–2400. doi: 10.1128/jvi.69.4.2393-2400.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. Macchia D., Almerigogna F., Parronchi P., Ravina A., Maggi E., Romagnani S. Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature. 1993 Jun 3;363(6428):464–466. doi: 10.1038/363464a0. [DOI] [PubMed] [Google Scholar]
  232. Macchia D., Parronchi P., Piccinni M. P., Simonelli C., Mazzetti M., Ravina A., Milo D., Maggi E., Romagnani S. In vitro infection with HIV enables human CD4+ T cell clones to induce noncognate contact-dependent polyclonal B cell activation. J Immunol. 1991 May 15;146(10):3413–3418. [PubMed] [Google Scholar]
  233. Maciejewski J. P., Weichold F. F., Young N. S. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol. 1994 Nov 1;153(9):4303–4310. [PubMed] [Google Scholar]
  234. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 1986 Nov 7;47(3):333–348. doi: 10.1016/0092-8674(86)90590-8. [DOI] [PubMed] [Google Scholar]
  235. Maddon P. J., Littman D. R., Godfrey M., Maddon D. E., Chess L., Axel R. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell. 1985 Aug;42(1):93–104. doi: 10.1016/s0092-8674(85)80105-7. [DOI] [PubMed] [Google Scholar]
  236. Maddon P. J., Molineaux S. M., Maddon D. E., Zimmerman K. A., Godfrey M., Alt F. W., Chess L., Axel R. Structure and expression of the human and mouse T4 genes. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9155–9159. doi: 10.1073/pnas.84.24.9155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  237. Maggi E., Mazzetti M., Ravina A., Annunziato F., de Carli M., Piccinni M. P., Manetti R., Carbonari M., Pesce A. M., del Prete G. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science. 1994 Jul 8;265(5169):244–248. doi: 10.1126/science.8023142. [DOI] [PubMed] [Google Scholar]
  238. Manca F., Habeshaw J. A., Dalgleish A. G. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4. Lancet. 1990 Apr 7;335(8693):811–815. doi: 10.1016/0140-6736(90)90935-x. [DOI] [PubMed] [Google Scholar]
  239. Mann D. L., Lasane F., Popovic M., Arthur L. O., Robey W. G., Blattner W. A., Newman M. J. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol. 1987 Apr 15;138(8):2640–2644. [PubMed] [Google Scholar]
  240. Mano H., Chermann J. C. Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses. 1991 Jan;7(1):83–88. doi: 10.1089/aid.1991.7.83. [DOI] [PubMed] [Google Scholar]
  241. Marschang P., Sodroski J., Würzner R., Dierich M. P. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur J Immunol. 1995 Jan;25(1):285–290. doi: 10.1002/eji.1830250147. [DOI] [PubMed] [Google Scholar]
  242. Martin S. J., Green D. R. Protease activation during apoptosis: death by a thousand cuts? Cell. 1995 Aug 11;82(3):349–352. doi: 10.1016/0092-8674(95)90422-0. [DOI] [PubMed] [Google Scholar]
  243. Martin S. J., Matear P. M., Vyakarnam A. HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells. J Immunol. 1994 Jan 1;152(1):330–342. [PubMed] [Google Scholar]
  244. Marx J. Clue found to T cell loss in AIDS. Science. 1991 Nov 8;254(5033):798–800. doi: 10.1126/science.1948062. [DOI] [PubMed] [Google Scholar]
  245. Mascola J. R., Mathieson B. J., Zack P. M., Walker M. C., Halstead S. B., Burke D. S. Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses. 1993 Dec;9(12):1175–1184. doi: 10.1089/aid.1993.9.1175. [DOI] [PubMed] [Google Scholar]
  246. Matthews T. J. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res Hum Retroviruses. 1994 Jun;10(6):631–632. doi: 10.1089/aid.1994.10.631. [DOI] [PubMed] [Google Scholar]
  247. Matthews T. J., Weinhold K. J., Lyerly H. K., Langlois A. J., Wigzell H., Bolognesi D. P. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5424–5428. doi: 10.1073/pnas.84.15.5424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Maury W., Potts B. J., Rabson A. B. HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J Infect Dis. 1989 Oct;160(4):583–588. doi: 10.1093/infdis/160.4.583. [DOI] [PubMed] [Google Scholar]
  249. McCloskey T. W., Oyaizu N., Kaplan M., Pahwa S. Expression of the Fas antigen in patients infected with human immunodeficiency virus. Cytometry. 1995 Jun 15;22(2):111–114. doi: 10.1002/cyto.990220206. [DOI] [PubMed] [Google Scholar]
  250. McCune J. M. HIV-1: the infective process in vivo. Cell. 1991 Jan 25;64(2):351–363. doi: 10.1016/0092-8674(91)90644-e. [DOI] [PubMed] [Google Scholar]
  251. McCune J. M., Rabin L. B., Feinberg M. B., Lieberman M., Kosek J. C., Reyes G. R., Weissman I. L. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 1988 Apr 8;53(1):55–67. doi: 10.1016/0092-8674(88)90487-4. [DOI] [PubMed] [Google Scholar]
  252. McFadden D. C., Powles M. A., Smith J. G., Flattery A. M., Bartizal K., Schmatz D. M. Use of anti-CD4+ hybridoma cells to induce Pneumocystis carinii in mice. Infect Immun. 1994 Nov;62(11):4887–4892. doi: 10.1128/iai.62.11.4887-4892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. Meltzer M. S., Skillman D. R., Hoover D. L., Hanson B. D., Turpin J. A., Kalter D. C., Gendelman H. E. Macrophages and the human immunodeficiency virus. Immunol Today. 1990 Jun;11(6):217–223. doi: 10.1016/0167-5699(90)90086-o. [DOI] [PubMed] [Google Scholar]
  254. Merrill J. E., Chen I. S. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 1991 Jul;5(10):2391–2397. doi: 10.1096/fasebj.5.10.2065887. [DOI] [PubMed] [Google Scholar]
  255. Merrill J. E., Koyanagi Y., Chen I. S. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989 Oct;63(10):4404–4408. doi: 10.1128/jvi.63.10.4404-4408.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Mestecky J., Jackson S. Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol. 1994 Sep;14(5):259–272. doi: 10.1007/BF01540979. [DOI] [PubMed] [Google Scholar]
  257. Meyaard L., Kuiper H., Otto S. A., Wolthers K. C., van Lier R. A., Miedema F. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur J Immunol. 1995 Jan;25(1):232–237. doi: 10.1002/eji.1830250138. [DOI] [PubMed] [Google Scholar]
  258. Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed death of T cells in HIV-1 infection. Science. 1992 Jul 10;257(5067):217–219. doi: 10.1126/science.1352911. [DOI] [PubMed] [Google Scholar]
  259. Meyaard L., Otto S. A., Keet I. P., Roos M. T., Miedema F. Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease. J Clin Invest. 1994 Mar;93(3):982–988. doi: 10.1172/JCI117105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  260. Meyaard L., Schuitemaker H., Miedema F. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol Today. 1993 Apr;14(4):161–164. doi: 10.1016/0167-5699(93)90279-T. [DOI] [PubMed] [Google Scholar]
  261. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., Morfeldt-Månson L., Asjö B., Wain-Hobson S. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell. 1989 Sep 8;58(5):901–910. doi: 10.1016/0092-8674(89)90942-2. [DOI] [PubMed] [Google Scholar]
  262. Miedema F., Petit A. J., Terpstra F. G., Schattenkerk J. K., de Wolf F., Al B. J., Roos M., Lange J. M., Danner S. A., Goudsmit J. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest. 1988 Dec;82(6):1908–1914. doi: 10.1172/JCI113809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Mittler R. S., Hoffmann M. K. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science. 1989 Sep 22;245(4924):1380–1382. doi: 10.1126/science.2571187. [DOI] [PubMed] [Google Scholar]
  264. Mizukami T., Fuerst T. R., Berger E. A., Moss B. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9273–9277. doi: 10.1073/pnas.85.23.9273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Mizuochi T., Matthews T. J., Kato M., Hamako J., Titani K., Solomon J., Feizi T. Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues. J Biol Chem. 1990 May 25;265(15):8519–8524. [PubMed] [Google Scholar]
  266. Molina J. M., Scadden D. T., Byrn R., Dinarello C. A., Groopman J. E. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. J Clin Invest. 1989 Sep;84(3):733–737. doi: 10.1172/JCI114230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  267. Molina J. M., Scadden D. T., Sakaguchi M., Fuller B., Woon A., Groopman J. E. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 1990 Dec 15;76(12):2476–2482. [PubMed] [Google Scholar]
  268. Mollace V., Colasanti M., Persichini T., Bagetta G., Lauro G. M., Nistico G. HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells. Biochem Biophys Res Commun. 1993 Jul 15;194(1):439–445. doi: 10.1006/bbrc.1993.1839. [DOI] [PubMed] [Google Scholar]
  269. Monroe J. G., Silberstein L. E. HIV-mediated B-lymphocyte activation and lymphomagenesis. J Clin Immunol. 1995 Mar;15(2):61–68. doi: 10.1007/BF01541733. [DOI] [PubMed] [Google Scholar]
  270. Mosier D., Sieburg H. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol Today. 1994 Jul;15(7):332–339. doi: 10.1016/0167-5699(94)90081-7. [DOI] [PubMed] [Google Scholar]
  271. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  272. Mountz J. D., Zhou T., Wu J., Wang W., Su X., Cheng J. Regulation of apoptosis in immune cells. J Clin Immunol. 1995 Jan;15(1):1–16. doi: 10.1007/BF01489485. [DOI] [PubMed] [Google Scholar]
  273. Muro-Cacho C. A., Pantaleo G., Fauci A. S. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol. 1995 May 15;154(10):5555–5566. [PubMed] [Google Scholar]
  274. Müller F., Rollag H., Frøland S. S. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin Exp Immunol. 1990 Oct;82(1):10–15. doi: 10.1111/j.1365-2249.1990.tb05396.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Müller W. E., Schröder H. C., Ushijima H., Dapper J., Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol. 1992 Jul 1;226(3):209–214. doi: 10.1016/0922-4106(92)90063-2. [DOI] [PubMed] [Google Scholar]
  276. Nabavi N., Freeman G. J., Gault A., Godfrey D., Nadler L. M., Glimcher L. H. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature. 1992 Nov 19;360(6401):266–268. doi: 10.1038/360266a0. [DOI] [PubMed] [Google Scholar]
  277. Nair M. P., Pottathil R., Heimer E. P., Schwartz S. A. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6498–6502. doi: 10.1073/pnas.85.17.6498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  278. Nakajima K., Martínez-Maza O., Hirano T., Breen E. C., Nishanian P. G., Salazar-Gonzalez J. F., Fahey J. L., Kishimoto T. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol. 1989 Jan 15;142(2):531–536. [PubMed] [Google Scholar]
  279. Nara P. L., Garrity R. R., Goudsmit J. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 1991 Jul;5(10):2437–2455. doi: 10.1096/fasebj.5.10.1712328. [DOI] [PubMed] [Google Scholar]
  280. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992 Sep;6(12):3051–3064. [PubMed] [Google Scholar]
  281. Nisini R., Aiuti A., Matricardi P. M., Fattorossi A., Ferlini C., Biselli R., Mezzaroma I., Pinter E., D'Amelio R. Lack of evidence for a superantigen in lymphocytes from HIV-discordant monozygotic twins. AIDS. 1994 Apr;8(4):443–449. doi: 10.1097/00002030-199404000-00005. [DOI] [PubMed] [Google Scholar]
  282. Nottet H. S., Gendelman H. E. Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today. 1995 Sep;16(9):441–448. doi: 10.1016/0167-5699(95)80022-0. [DOI] [PubMed] [Google Scholar]
  283. Nottet H. S., de Graaf L., de Vos N. M., Bakker L. J., van Strijp J. A., Visser M. R., Verhoef J. Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection. J Infect Dis. 1993 Jul;168(1):84–91. doi: 10.1093/infdis/168.1.84. [DOI] [PubMed] [Google Scholar]
  284. Nye K. E., Pinching A. J. HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway. AIDS. 1990 Jan;4(1):41–45. doi: 10.1097/00002030-199001000-00006. [DOI] [PubMed] [Google Scholar]
  285. Nye K. E., Riley G. A., Pinching A. J. The defect seen in the phosphatidylinositol hydrolysis pathway in HIV-infected lymphocytes and lymphoblastoid cells is due to inhibition of the inositol 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase. Clin Exp Immunol. 1992 Jul;89(1):89–93. doi: 10.1111/j.1365-2249.1992.tb06883.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  286. Nygren A., Bergman T., Matthews T., Jörnvall H., Wigzell H. 95- and 25-kDa fragments of the human immunodeficiency virus envelope glycoprotein gp120 bind to the CD4 receptor. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6543–6546. doi: 10.1073/pnas.85.17.6543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Oh S. K., Cruikshank W. W., Raina J., Blanchard G. C., Adler W. H., Walker J., Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr. 1992;5(3):251–256. [PubMed] [Google Scholar]
  288. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. doi: 10.1016/0092-8674(87)90507-1. [DOI] [PubMed] [Google Scholar]
  289. Olive D., Mawas C. Therapeutic applications of anti-CD4 antibodies. Crit Rev Ther Drug Carrier Syst. 1993;10(1):29–63. [PubMed] [Google Scholar]
  290. Oravecz T., Norcross M. A. Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120. AIDS Res Hum Retroviruses. 1993 Oct;9(10):945–955. doi: 10.1089/aid.1993.9.945. [DOI] [PubMed] [Google Scholar]
  291. Oravecz T., Roderiquez G., Koffi J., Wang J., Ditto M., Bou-Habib D. C., Lusso P., Norcross M. A. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat Med. 1995 Sep;1(9):919–926. doi: 10.1038/nm0995-919. [DOI] [PubMed] [Google Scholar]
  292. Orloff G. M., Kennedy M. S., Dawson C., McDougal J. S. HIV-1 binding to CD4 T cells does not induce a Ca2+ influx or lead to activation of protein kinases. AIDS Res Hum Retroviruses. 1991 Jul;7(7):587–593. doi: 10.1089/aid.1991.7.587. [DOI] [PubMed] [Google Scholar]
  293. Oyaizu N., Chirmule N., Kalyanaraman V. S., Hall W. W., Pahwa R., Shuster M., Pahwa S. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2379–2383. doi: 10.1073/pnas.87.6.2379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  294. Oyaizu N., Chirmule N., Ohnishi Y., Kalyanaraman V. S., Pahwa S. Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones. J Virol. 1991 Nov;65(11):6277–6282. doi: 10.1128/jvi.65.11.6277-6282.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Oyaizu N., Chirmule N., Pahwa S. Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in class II major histocompatibility complex-restricted antigen-specific T helper clones. T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals. J Clin Invest. 1992 Jun;89(6):1807–1816. doi: 10.1172/JCI115785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  296. Oyaizu N., McCloskey T. W., Coronesi M., Chirmule N., Kalyanaraman V. S., Pahwa S. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 1993 Dec 1;82(11):3392–3400. [PubMed] [Google Scholar]
  297. Oyaizu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S., Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-gamma and tumor necrosis factor-alpha secretion. Blood. 1994 Oct 15;84(8):2622–2631. [PubMed] [Google Scholar]
  298. Oyaizu N., Pahwa S. Role of apoptosis in HIV disease pathogenesis. J Clin Immunol. 1995 Sep;15(5):217–231. doi: 10.1007/BF01540879. [DOI] [PubMed] [Google Scholar]
  299. Pahwa S. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management. Pediatr Infect Dis J. 1988 May;7(5 Suppl):S61–S71. [PubMed] [Google Scholar]
  300. Pahwa S., Pahwa R., Good R. A., Gallo R. C., Saxinger C. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9124–9128. doi: 10.1073/pnas.83.23.9124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Pal R., Nair B. C., Hoke G. M., Sarngadharan M. G., Edidin M. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1). J Cell Physiol. 1991 May;147(2):326–332. doi: 10.1002/jcp.1041470219. [DOI] [PubMed] [Google Scholar]
  302. Pandolfi F., Pierdominici M., Oliva A., D'Offizi G., Mezzaroma I., Mollicone B., Giovannetti A., Rainaldi L., Quinti I., Aiuti F. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 15;9(5):450–458. [PubMed] [Google Scholar]
  303. Pantaleo G., Demarest J. F., Soudeyns H., Graziosi C., Denis F., Adelsberger J. W., Borrow P., Saag M. S., Shaw G. M., Sekaly R. P. Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature. 1994 Aug 11;370(6489):463–467. doi: 10.1038/370463a0. [DOI] [PubMed] [Google Scholar]
  304. Parker D. C. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–360. doi: 10.1146/annurev.iy.11.040193.001555. [DOI] [PubMed] [Google Scholar]
  305. Perlmutter R. M., Levin S. D., Appleby M. W., Anderson S. J., Alberola-Ila J. Regulation of lymphocyte function by protein phosphorylation. Annu Rev Immunol. 1993;11:451–499. doi: 10.1146/annurev.iy.11.040193.002315. [DOI] [PubMed] [Google Scholar]
  306. Peters A. M., Jäger F. S., Warneke A., Müller K., Brunkhorst U., Schedel I., Gahr M. Cytokine secretion by peripheral blood monocytes from human immunodeficiency virus-infected patients is normal. Clin Immunol Immunopathol. 1991 Dec;61(3):343–352. doi: 10.1016/s0090-1229(05)80006-6. [DOI] [PubMed] [Google Scholar]
  307. Peterson A., Seed B. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell. 1988 Jul 1;54(1):65–72. doi: 10.1016/0092-8674(88)90180-8. [DOI] [PubMed] [Google Scholar]
  308. Petit A. J., Tersmette M., Terpstra F. G., de Goede R. E., van Lier R. A., Miedema F. Decreased accessory cell function by human monocytic cells after infection with HIV. J Immunol. 1988 Mar 1;140(5):1485–1489. [PubMed] [Google Scholar]
  309. Phillips D. M. The role of cell-to-cell transmission in HIV infection. AIDS. 1994 Jun;8(6):719–731. doi: 10.1097/00002030-199406000-00001. [DOI] [PubMed] [Google Scholar]
  310. Pietraforte D., Tritarelli E., Testa U., Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol. 1994 Feb;55(2):175–182. doi: 10.1002/jlb.55.2.175. [DOI] [PubMed] [Google Scholar]
  311. Pinching A. J., Nye K. E. Defective signal transduction--a common pathway for cellular dysfunction in HIV infection? Immunol Today. 1990 Jul;11(7):256–259. doi: 10.1016/0167-5699(90)90100-n. [DOI] [PubMed] [Google Scholar]
  312. Posnett D. N., Kabak S., Hodtsev A. S., Goldberg E. A., Asch A. T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS. AIDS. 1993 May;7(5):625–631. doi: 10.1097/00002030-199305000-00003. [DOI] [PubMed] [Google Scholar]
  313. Prasad K. V., Kapeller R., Janssen O., Repke H., Duke-Cohan J. S., Cantley L. C., Rudd C. E. Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol Cell Biol. 1993 Dec;13(12):7708–7717. doi: 10.1128/mcb.13.12.7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  314. Prasad K. V., Rudd C. E. A Raf-1-related p110 polypeptide associates with the CD4-p56lck complex in T cells. Mol Cell Biol. 1992 Nov;12(11):5260–5267. doi: 10.1128/mcb.12.11.5260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Pulliam L., West D., Haigwood N., Swanson R. A. HIV-1 envelope gp120 alters astrocytes in human brain cultures. AIDS Res Hum Retroviruses. 1993 May;9(5):439–444. doi: 10.1089/aid.1993.9.439. [DOI] [PubMed] [Google Scholar]
  316. Radrizzani M., Accornero P., Amidei A., Aiello A., Delia D., Kurrle R., Colombo M. P. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivation. Cell Immunol. 1995 Mar;161(1):14–21. doi: 10.1006/cimm.1995.1003. [DOI] [PubMed] [Google Scholar]
  317. Rahemtulla A., Fung-Leung W. P., Schilham M. W., Kündig T. M., Sambhara S. R., Narendran A., Arabian A., Wakeham A., Paige C. J., Zinkernagel R. M. Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature. 1991 Sep 12;353(6340):180–184. doi: 10.1038/353180a0. [DOI] [PubMed] [Google Scholar]
  318. Ramsdell F., Fowlkes B. J. Engagement of CD4 and CD8 accessory molecules is required for T cell maturation. J Immunol. 1989 Sep 1;143(5):1467–1471. [PubMed] [Google Scholar]
  319. Rautonen J., Rautonen N., Martin N. L., Wara D. W. HIV type 1 Tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res Hum Retroviruses. 1994 Jul;10(7):781–785. doi: 10.1089/aid.1994.10.781. [DOI] [PubMed] [Google Scholar]
  320. Re M. C., Zauli G., Gibellini D., Furlini G., Ramazzotti E., Monari P., Ranieri S., Capitani S., La Placa M. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS. 1993 Aug;7(8):1049–1055. doi: 10.1097/00002030-199308000-00004. [DOI] [PubMed] [Google Scholar]
  321. Rebai N., Pantaleo G., Demarest J. F., Ciurli C., Soudeyns H., Adelsberger J. W., Vaccarezza M., Walker R. E., Sekaly R. P., Fauci A. S. Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1529–1533. doi: 10.1073/pnas.91.4.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Reiher W. E., 3rd, Blalock J. E., Brunck T. K. Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9188–9192. doi: 10.1073/pnas.83.23.9188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  323. Robbins D. S., Shirazi Y., Drysdale B. E., Lieberman A., Shin H. S., Shin M. L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol. 1987 Oct 15;139(8):2593–2597. [PubMed] [Google Scholar]
  324. Robey E., Axel R. CD4: collaborator in immune recognition and HIV infection. Cell. 1990 Mar 9;60(5):697–700. doi: 10.1016/0092-8674(90)90082-p. [DOI] [PubMed] [Google Scholar]
  325. Robey E., Fowlkes B. J. Selective events in T cell development. Annu Rev Immunol. 1994;12:675–705. doi: 10.1146/annurev.iy.12.040194.003331. [DOI] [PubMed] [Google Scholar]
  326. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol. 1994;12:227–257. doi: 10.1146/annurev.iy.12.040194.001303. [DOI] [PubMed] [Google Scholar]
  327. Romagnani S., Maggi E., Del Prete G. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res Hum Retroviruses. 1994 May;10(5):iii–ix. doi: 10.1089/aid.1994.10.iii. [DOI] [PubMed] [Google Scholar]
  328. Rosenstein Y., Burakoff S. J., Herrmann S. H. HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol. 1990 Jan 15;144(2):526–531. [PubMed] [Google Scholar]
  329. Ruegg C. L., Monell C. R., Strand M. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J Virol. 1989 Aug;63(8):3257–3260. doi: 10.1128/jvi.63.8.3257-3260.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  330. Rusche J. R., Javaherian K., McDanal C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc Natl Acad Sci U S A. 1988 May;85(9):3198–3202. doi: 10.1073/pnas.85.9.3198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Ryu S. E., Kwong P. D., Truneh A., Porter T. G., Arthos J., Rosenberg M., Dai X. P., Xuong N. H., Axel R., Sweet R. W. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature. 1990 Nov 29;348(6300):419–426. doi: 10.1038/348419a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  332. Salmon M., Pilling D., Borthwick N. J., Viner N., Janossy G., Bacon P. A., Akbar A. N. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol. 1994 Apr;24(4):892–899. doi: 10.1002/eji.1830240417. [DOI] [PubMed] [Google Scholar]
  333. Sattentau Q. J., Moore J. P. The role of CD4 in HIV binding and entry. Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59–66. doi: 10.1098/rstb.1993.0136. [DOI] [PubMed] [Google Scholar]
  334. Schneider-Schaulies J., Schneider-Schaulies S., Brinkmann R., Tas P., Halbrügge M., Walter U., Holmes H. C., Ter Meulen V. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology. 1992 Dec;191(2):765–772. doi: 10.1016/0042-6822(92)90252-k. [DOI] [PubMed] [Google Scholar]
  335. Schneider J., Kaaden O., Copeland T. D., Oroszlan S., Hunsmann G. Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus. J Gen Virol. 1986 Nov;67(Pt 11):2533–2538. doi: 10.1099/0022-1317-67-11-2533. [DOI] [PubMed] [Google Scholar]
  336. Schnittman S. M., Denning S. M., Greenhouse J. J., Justement J. S., Baseler M., Kurtzberg J., Haynes B. F., Fauci A. S. Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7727–7731. doi: 10.1073/pnas.87.19.7727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  337. Schnittman S. M., Fauci A. S. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv Intern Med. 1994;39:305–355. [PubMed] [Google Scholar]
  338. Schnittman S. M., Lane H. C., Higgins S. E., Folks T., Fauci A. S. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science. 1986 Sep 5;233(4768):1084–1086. doi: 10.1126/science.3016902. [DOI] [PubMed] [Google Scholar]
  339. Schnittman S. M., Psallidopoulos M. C., Lane H. C., Thompson L., Baseler M., Massari F., Fox C. H., Salzman N. P., Fauci A. S. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science. 1989 Jul 21;245(4915):305–308. doi: 10.1126/science.2665081. [DOI] [PubMed] [Google Scholar]
  340. Schooley R. T., Merigan T. C., Gaut P., Hirsch M. S., Holodniy M., Flynn T., Liu S., Byington R. E., Henochowicz S., Gubish E. Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase I-II escalating dosage trial. Ann Intern Med. 1990 Feb 15;112(4):247–253. doi: 10.7326/0003-4819-112-4-247. [DOI] [PubMed] [Google Scholar]
  341. Schwartz O., Alizon M., Heard J. M., Danos O. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology. 1994 Jan;198(1):360–365. doi: 10.1006/viro.1994.1042. [DOI] [PubMed] [Google Scholar]
  342. Schwartz R. H. A cell culture model for T lymphocyte clonal anergy. Science. 1990 Jun 15;248(4961):1349–1356. doi: 10.1126/science.2113314. [DOI] [PubMed] [Google Scholar]
  343. Selmaj K. W., Farooq M., Norton W. T., Raine C. S., Brosnan C. F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol. 1990 Jan 1;144(1):129–135. [PubMed] [Google Scholar]
  344. Shalaby M. R., Krowka J. F., Gregory T. J., Hirabayashi S. E., McCabe S. M., Kaufman D. S., Stites D. P., Ammann A. J. The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol. 1987 Nov;110(1):140–148. doi: 10.1016/0008-8749(87)90108-0. [DOI] [PubMed] [Google Scholar]
  345. Shearer G. M., Clerici M. Abnormalities of immune regulation in human immunodeficiency virus infection. Pediatr Res. 1993 Jan;33(1 Suppl):S71–S75. doi: 10.1203/00006450-199305001-00410. [DOI] [PubMed] [Google Scholar]
  346. Sheppard H. W., Ascher M. S. The relationship between AIDS and immunologic tolerance. J Acquir Immune Defic Syndr. 1992;5(2):143–147. [PubMed] [Google Scholar]
  347. Shi Y., Glynn J. M., Guilbert L. J., Cotter T. G., Bissonnette R. P., Green D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 1992 Jul 10;257(5067):212–214. doi: 10.1126/science.1378649. [DOI] [PubMed] [Google Scholar]
  348. Shioda T., Levy J. A., Cheng-Mayer C. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature. 1991 Jan 10;349(6305):167–169. doi: 10.1038/349167a0. [DOI] [PubMed] [Google Scholar]
  349. Shiratsuchi H., Johnson J. L., Toossi Z., Ellner J. J. Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. J Clin Invest. 1994 Feb;93(2):885–891. doi: 10.1172/JCI117044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  350. Sica A., Tan T. H., Rice N., Kretzschmar M., Ghosh P., Young H. A. The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1740–1744. doi: 10.1073/pnas.89.5.1740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  351. Silvestris F., Williams R. C., Jr, Dammacco F. Autoreactivity in HIV-1 infection: the role of molecular mimicry. Clin Immunol Immunopathol. 1995 Jun;75(3):197–205. doi: 10.1006/clin.1995.1072. [DOI] [PubMed] [Google Scholar]
  352. Sloan-Lancaster J., Shaw A. S., Rothbard J. B., Allen P. M. Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 1994 Dec 2;79(5):913–922. doi: 10.1016/0092-8674(94)90080-9. [DOI] [PubMed] [Google Scholar]
  353. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. 1986 Jul 31-Aug 6Nature. 322(6078):470–474. doi: 10.1038/322470a0. [DOI] [PubMed] [Google Scholar]
  354. Soliven B., Albert J. Tumor necrosis factor modulates Ca2+ currents in cultured sympathetic neurons. J Neurosci. 1992 Jul;12(7):2665–2671. doi: 10.1523/JNEUROSCI.12-07-02665.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  355. Soliven B., Takeda M., Szuchet S. Depolarizing agents and tumor necrosis factor-alpha modulate protein phosphorylation in oligodendrocytes. J Neurosci Res. 1994 May 1;38(1):91–100. doi: 10.1002/jnr.490380112. [DOI] [PubMed] [Google Scholar]
  356. Soudeyns H., Rebai N., Pantaleo G. P., Ciurli C., Boghossian T., Sékaly R. P., Fauci A. S. The T cell receptor V beta repertoire in HIV-1 infection and disease. Semin Immunol. 1993 Jun;5(3):175–185. doi: 10.1006/smim.1993.1021. [DOI] [PubMed] [Google Scholar]
  357. Soudeyns H., Routy J. P., Sékaly R. P. Comparative analysis of the T cell receptor V beta repertoire in various lymphoid tissues from HIV-infected patients: evidence for an HIV-associated superantigen. Leukemia. 1994 Apr;8 (Suppl 1):S95–S97. [PubMed] [Google Scholar]
  358. Soula M., Fagard R., Fischer S. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p56lck autophosphorylation and kinase activity. Int Immunol. 1992 Feb;4(2):295–299. doi: 10.1093/intimm/4.2.295. [DOI] [PubMed] [Google Scholar]
  359. Sperber K., Hamrang G., Louie M. J., Kalb T., Banerjee R., Choi H. S., Paronetto F., Mayer L. Progressive impairment of monocytic function in HIV-1-infected human macrophage hybridomas. AIDS Res Hum Retroviruses. 1993 Jul;9(7):657–667. doi: 10.1089/aid.1993.9.657. [DOI] [PubMed] [Google Scholar]
  360. Spivak J. L., Bender B. S., Quinn T. C. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med. 1984 Aug;77(2):224–228. doi: 10.1016/0002-9343(84)90695-8. [DOI] [PubMed] [Google Scholar]
  361. Srinivas S. K., Srinivas R. V., Anantharamaiah G. M., Compans R. W., Segrest J. P. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem. 1993 Oct 25;268(30):22895–22899. [PubMed] [Google Scholar]
  362. Staal F. J., Ela S. W., Roederer M., Anderson M. T., Herzenberg L. A., Herzenberg L. A. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 1992 Apr 11;339(8798):909–912. doi: 10.1016/0140-6736(92)90939-z. [DOI] [PubMed] [Google Scholar]
  363. Stamatatos L., Cheng-Mayer C. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J Virol. 1993 Sep;67(9):5635–5639. doi: 10.1128/jvi.67.9.5635-5639.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  364. Stanley S. K., Kessler S. W., Justement J. S., Schnittman S. M., Greenhouse J. J., Brown C. C., Musongela L., Musey K., Kapita B., Fauci A. S. CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol. 1992 Jul 15;149(2):689–697. [PubMed] [Google Scholar]
  365. Stanley S. K., McCune J. M., Kaneshima H., Justement J. S., Sullivan M., Boone E., Baseler M., Adelsberger J., Bonyhadi M., Orenstein J. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med. 1993 Oct 1;178(4):1151–1163. doi: 10.1084/jem.178.4.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  366. Stella C. C., Ganser A., Hoelzer D. Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest. 1987 Aug;80(2):286–293. doi: 10.1172/JCI113071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  367. Steller H. Mechanisms and genes of cellular suicide. Science. 1995 Mar 10;267(5203):1445–1449. doi: 10.1126/science.7878463. [DOI] [PubMed] [Google Scholar]
  368. Stewart S. J., Fujimoto J., Levy R. Human T lymphocytes and monocytes bear the same Leu-3(T4) antigen. J Immunol. 1986 May 15;136(10):3773–3778. [PubMed] [Google Scholar]
  369. Stoiber H., Ebenbichler C. F., Thielens N. M., Arlaud G. J., Dierich M. P. HIV-1 rsgp41 depends on calcium for binding of human c1q but not for binding of gp120. Mol Immunol. 1995 Apr;32(5):371–374. doi: 10.1016/0161-5890(94)00156-u. [DOI] [PubMed] [Google Scholar]
  370. Stoiber H., Ebenbichler C., Schneider R., Janatova J., Dierich M. P. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS. 1995 Jan;9(1):19–26. doi: 10.1097/00002030-199501000-00003. [DOI] [PubMed] [Google Scholar]
  371. Su L., Kaneshima H., Bonyhadi M., Salimi S., Kraft D., Rabin L., McCune J. M. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity. 1995 Jan;2(1):25–36. doi: 10.1016/1074-7613(95)90076-4. [DOI] [PubMed] [Google Scholar]
  372. Sugiura K., Oyaizu N., Pahwa R., Kalyanaraman V. S., Pahwa S. Effect of human immunodeficiency virus-1 envelope glycoprotein on in vitro hematopoiesis of umbilical cord blood. Blood. 1992 Sep 15;80(6):1463–1469. [PubMed] [Google Scholar]
  373. Szawlowski P. W., Hanke T., Randall R. E. Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas. AIDS. 1993 Jul;7(7):1018–1018. doi: 10.1097/00002030-199307000-00019. [DOI] [PubMed] [Google Scholar]
  374. Sölder B. M., Schulz T. F., Hengster P., Löwer J., Larcher C., Bitterlich G., Kurth R., Wachter H., Dierich M. P. HIV and HIV-infected cells differentially activate the human complement system independent of antibody. Immunol Lett. 1989 Aug;22(2):135–145. doi: 10.1016/0165-2478(89)90180-6. [DOI] [PubMed] [Google Scholar]
  375. Süsal C., Kirschfink M., Kröpelin M., Daniel V., Opelz G. Complement activation by recombinant HIV-1 glycoprotein gp120. J Immunol. 1994 Jun 15;152(12):6028–6034. [PubMed] [Google Scholar]
  376. Takahashi T., Tanaka M., Brannan C. I., Jenkins N. A., Copeland N. G., Suda T., Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994 Mar 25;76(6):969–976. doi: 10.1016/0092-8674(94)90375-1. [DOI] [PubMed] [Google Scholar]
  377. Tanaka K. E., Hatch W. C., Kress Y., Soeiro R., Calvelli T., Rashbaum W. K., Rubinstein A., Lyman W. D. HIV-1 infection of human fetal thymocytes. J Acquir Immune Defic Syndr. 1992;5(1):94–101. [PubMed] [Google Scholar]
  378. Telfer J. C., Rudd C. E. A 32-kD GTP-binding protein associated with the CD4-p56lck and CD8-p56lck T cell receptor complexes. Science. 1991 Oct 18;254(5030):439–441. doi: 10.1126/science.1925604. [DOI] [PubMed] [Google Scholar]
  379. Terai C., Kornbluth R. S., Pauza C. D., Richman D. D., Carson D. A. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest. 1991 May;87(5):1710–1715. doi: 10.1172/JCI115188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  380. Terpstra F. G., Al B. J., Roos M. T., De Wolf F., Goudsmit J., Schellekens P. T., Miedema F. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur J Immunol. 1989 Apr;19(4):667–673. doi: 10.1002/eji.1830190415. [DOI] [PubMed] [Google Scholar]
  381. Than S., Oyaizu N., Pahwa R. N., Kalyanaraman V. S., Pahwa S. Effect of human immunodeficiency virus type-1 envelope glycoprotein gp160 on cytokine production from cord-blood T cells. Blood. 1994 Jul 1;84(1):184–188. [PubMed] [Google Scholar]
  382. Theodore A. C., Kornfeld H., Wallace R. P., Cruikshank W. W. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J Acquir Immune Defic Syndr. 1994 Sep;7(9):899–907. [PubMed] [Google Scholar]
  383. Thieblemont N., Haeffner-Cavaillon N., Weiss L., Maillet F., Kazatchkine M. D. Complement activation by gp160 glycoprotein of HIV-1. AIDS Res Hum Retroviruses. 1993 Mar;9(3):229–233. doi: 10.1089/aid.1993.9.229. [DOI] [PubMed] [Google Scholar]
  384. Thielens N. M., Bally I. M., Ebenbichler C. F., Dierich M. P., Arlaud G. J. Further characterization of the interaction between the C1q subcomponent of human C1 and the transmembrane envelope glycoprotein gp41 of HIV-1. J Immunol. 1993 Dec 1;151(11):6583–6592. [PubMed] [Google Scholar]
  385. Thielens N. M., Illy C., Bally I. M., Arlaud G. J. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q. Biochem J. 1994 Jul 15;301(Pt 2):509–516. doi: 10.1042/bj3010509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  386. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 1995 Mar 10;267(5203):1456–1462. doi: 10.1126/science.7878464. [DOI] [PubMed] [Google Scholar]
  387. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 1994 Jan 13;367(6459):188–193. doi: 10.1038/367188a0. [DOI] [PubMed] [Google Scholar]
  388. Tremblay M., Numazaki K., Goldman H., Wainberg M. A. Infection of human thymic lymphocytes by HIV-1. J Acquir Immune Defic Syndr. 1990;3(4):356–360. [PubMed] [Google Scholar]
  389. Tsygankov A. Y., Bröker B. M., Guse A. H., Meinke U., Roth E., Rossmann C., Emmrich F. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3. J Leukoc Biol. 1993 Nov;54(5):430–438. doi: 10.1002/jlb.54.5.430. [DOI] [PubMed] [Google Scholar]
  390. Ullman K. S., Northrop J. P., Verweij C. L., Crabtree G. R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol. 1990;8:421–452. doi: 10.1146/annurev.iy.08.040190.002225. [DOI] [PubMed] [Google Scholar]
  391. Umlauf S. W., Beverly B., Kang S. M., Brorson K., Tran A. C., Schwartz R. H. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunol Rev. 1993 Jun;133:177–197. doi: 10.1111/j.1600-065x.1993.tb01516.x. [DOI] [PubMed] [Google Scholar]
  392. Vaux D. L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 1994 Mar 11;76(5):777–779. doi: 10.1016/0092-8674(94)90350-6. [DOI] [PubMed] [Google Scholar]
  393. Vaux D. L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):786–789. doi: 10.1073/pnas.90.3.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  394. Wahl L. M., Corcoran M. L., Pyle S. W., Arthur L. O., Harel-Bellan A., Farrar W. L. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci U S A. 1989 Jan;86(2):621–625. doi: 10.1073/pnas.86.2.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  395. Wahl S. M., Allen J. B., Gartner S., Orenstein J. M., Popovic M., Chenoweth D. E., Arthur L. O., Farrar W. L., Wahl L. M. HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol. 1989 May 15;142(10):3553–3559. [PubMed] [Google Scholar]
  396. Wang H., Nishanian P., Fahey J. L. Characterization of immune suppression by a synthetic HIV gp41 peptide. Cell Immunol. 1995 Apr 1;161(2):236–243. doi: 10.1006/cimm.1995.1032. [DOI] [PubMed] [Google Scholar]
  397. Wang J. H., Yan Y. W., Garrett T. P., Liu J. H., Rodgers D. W., Garlick R. L., Tarr G. E., Husain Y., Reinherz E. L., Harrison S. C. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature. 1990 Nov 29;348(6300):411–418. doi: 10.1038/348411a0. [DOI] [PubMed] [Google Scholar]
  398. Wang Z. Q., Dudhane A., Orlikowsky T., Clarke K., Li X., Darzynkiewicz Z., Hoffmann M. K. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol. 1994 Jul;24(7):1549–1552. doi: 10.1002/eji.1830240714. [DOI] [PubMed] [Google Scholar]
  399. Wang Z. Q., Orlikowsky T., Dudhane A., Mittler R., Blum M., Lacy E., Riethmüller G., Hoffmann M. K. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur J Immunol. 1994 Jul;24(7):1553–1557. doi: 10.1002/eji.1830240715. [DOI] [PubMed] [Google Scholar]
  400. Watanabe-Fukunaga R., Brannan C. I., Copeland N. G., Jenkins N. A., Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 1992 Mar 26;356(6367):314–317. doi: 10.1038/356314a0. [DOI] [PubMed] [Google Scholar]
  401. Weber G. F., Cantor H. HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy. Med Hypotheses. 1993 Sep;41(3):247–250. doi: 10.1016/0306-9877(93)90241-h. [DOI] [PubMed] [Google Scholar]
  402. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995 Jan 12;373(6510):117–122. doi: 10.1038/373117a0. [DOI] [PubMed] [Google Scholar]
  403. Weinhold K. J., Lyerly H. K., Stanley S. D., Austin A. A., Matthews T. J., Bolognesi D. P. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol. 1989 May 1;142(9):3091–3097. [PubMed] [Google Scholar]
  404. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 1994 Jan 28;76(2):263–274. doi: 10.1016/0092-8674(94)90334-4. [DOI] [PubMed] [Google Scholar]
  405. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature. 1995 Jun 8;375(6531):497–500. doi: 10.1038/375497a0. [DOI] [PubMed] [Google Scholar]
  406. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  407. Wolf H., Müller Y., Salmen S., Wilmanns W., Jung G. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur J Immunol. 1994 Jun;24(6):1410–1417. doi: 10.1002/eji.1830240626. [DOI] [PubMed] [Google Scholar]
  408. Woronicz J. D., Calnan B., Ngo V., Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature. 1994 Jan 20;367(6460):277–281. doi: 10.1038/367277a0. [DOI] [PubMed] [Google Scholar]
  409. Wyllie A. H., Morris R. G., Smith A. L., Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol. 1984 Jan;142(1):67–77. doi: 10.1002/path.1711420112. [DOI] [PubMed] [Google Scholar]
  410. Yamashita T., Boros D. L. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni. J Immunol. 1990 Jul 15;145(2):724–731. [PubMed] [Google Scholar]
  411. Yarchoan R., Redfield R. R., Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986 Aug;78(2):439–447. doi: 10.1172/JCI112595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  412. Yeung M. C., Pulliam L., Lau A. S. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS. 1995 Feb;9(2):137–143. [PubMed] [Google Scholar]
  413. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 1989 May 1;169(5):1747–1756. doi: 10.1084/jem.169.5.1747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  414. Yoshida H., Koga Y., Moroi Y., Kimura G., Nomoto K. The effect of p56lck, a lymphocyte specific protein tyrosine kinase, on the syncytium formation induced by human immunodeficiency virus envelope glycoprotein. Int Immunol. 1992 Feb;4(2):233–242. doi: 10.1093/intimm/4.2.233. [DOI] [PubMed] [Google Scholar]
  415. Zagury J. F., Bernard J., Achour A., Astgen A., Lachgar A., Fall L., Carelli C., Issing W., Mbika J. P., Picard O. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7573–7577. doi: 10.1073/pnas.90.16.7573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  416. Zagury J. F., Cantalloube H., Bernard J., Mornon J. P., Bizzini B., Zagury D. Striking identity between HIV-1 envelope glycoprotein gp120 and its CD4 receptor. Lancet. 1992 Aug 22;340(8817):483–484. doi: 10.1016/0140-6736(92)91803-g. [DOI] [PubMed] [Google Scholar]
  417. Zambruno G., Mori L., Marconi A., Mongiardo N., De Rienzo B., Bertazzoni U., Giannetti A. Detection of HIV-1 in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol. 1991 Jun;96(6):979–982. doi: 10.1111/1523-1747.ep12476469. [DOI] [PubMed] [Google Scholar]
  418. Zauli G., Re M. C., Davis B., Sen L., Visani G., Gugliotta L., Furlini G., La Placa M. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood. 1992 May 15;79(10):2680–2687. [PubMed] [Google Scholar]
  419. Zauli G., Re M. C., Furlini G., Giovannini M., La Placa M. Human immunodeficiency virus type 1 envelope glycoprotein gp120-mediated killing of human haematopoietic progenitors (CD34+ cells). J Gen Virol. 1992 Feb;73(Pt 2):417–421. doi: 10.1099/0022-1317-73-2-417. [DOI] [PubMed] [Google Scholar]
  420. Zauli G., Re M. C., Visani G., Furlini G., La Placa M. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells. Arch Virol. 1992;122(3-4):271–280. doi: 10.1007/BF01317189. [DOI] [PubMed] [Google Scholar]
  421. Zauli G., Re M. C., Visani G., Furlini G., Mazza P., Vignoli M., La Placa M. Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis. 1992 Oct;166(4):710–716. doi: 10.1093/infdis/166.4.710. [DOI] [PubMed] [Google Scholar]
  422. Zembala M., Pryjma J., Plucienniczak A., Szczepanek A., Jasinski M., Ruggiero I., Piselli P., Colizzi V. Interaction of HIV-1 gp120 molecule fragments with human monocytes: different requirements for tumor necrosis factor-alpha and IL-6 production. Clin Immunol Immunopathol. 1995 May;75(2):131–139. doi: 10.1006/clin.1995.1062. [DOI] [PubMed] [Google Scholar]
  423. Zinkernagel R. M. Are HIV-specific CTL responses salutary or pathogenic? Curr Opin Immunol. 1995 Aug;7(4):462–470. doi: 10.1016/0952-7915(95)80089-1. [DOI] [PubMed] [Google Scholar]
  424. Zolla-Pazner S., Gorny M. K. Passive immunization for the prevention and treatment of HIV infection. AIDS. 1992 Nov;6(11):1235–1247. doi: 10.1097/00002030-199211000-00001. [DOI] [PubMed] [Google Scholar]
  425. Zorn N. E., Weill C. L., Russell D. H. The HIV protein, GP120, activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochem Biophys Res Commun. 1990 Feb 14;166(3):1133–1139. doi: 10.1016/0006-291x(90)90984-u. [DOI] [PubMed] [Google Scholar]
  426. von Laer D., Hufert F. T., Fenner T. E., Schwander S., Dietrich M., Schmitz H., Kern P. CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood. 1990 Oct 1;76(7):1281–1286. [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES